fluorouracil has been researched along with Melanoma in 202 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Melanoma: A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The lesions of 5 patients with multiple cutaneous metastases were treated topically, 5 days per week, with 5-fluorouracil in the morning and imiquimod at night." | 9.16 | Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil. ( Desmedt, E; Florin, V; Mortier, L; Vercambre-Darras, S, 2012) |
| "This study examined the effects of folate environment of oligochitosan nanoparticles on their cellular internalization profiles in human melanoma cells." | 7.96 | Folate-induced nanostructural changes of oligochitosan nanoparticles and their fate of cellular internalization by melanoma. ( Kumar, P; Musalli, AH; Roy, P; Talukdar, PD; Wong, TW, 2020) |
| "5-Fluorouracil delivery profiles in the form of chitosan-folate submicron particles through skin and melanoma cells in vitro were examined using microwaves as the penetration enhancer." | 7.88 | Chitosan-Carboxymethyl-5-Fluorouracil-Folate Conjugate Particles: Microwave Modulated Uptake by Skin and Melanoma Cells. ( Nawaz, A; Wong, TW, 2018) |
| " However, little information is available concerning whether lidocaine sensitizes the cytotoxicity of 5-fluorouracil (5-FU) in melanoma cells." | 7.85 | Lidocaine sensitizes the cytotoxicity of 5-fluorouacil in melanoma cells ( Huang, S; Liu, W; Wang, Y; Xie, J; Xing, Y; Zhang, R, 2017) |
| "To assess whether multiple low doses of 5-fluorouracil could repress myeloid derived suppressor cells in low frequency and, in turn, could enhance anti-tumor responses and promote a more prolonged survival in a murine melanoma model." | 7.81 | Multiple Low Doses of 5-Fluorouracil Diminishes Immunosuppression by Myeloid Derived Suppressor Cells in Murine Melanoma Model. ( Ajami, M; Ashourpour, M; Hadjati, J; Jadidi-Niaragh, F; Mirzaei, HR; Namdar, A; Rezaei, A, 2015) |
| " In this study, the influence of Pheroid™ technology, which is a unique colloidal drug delivery system, on the skin permeation and antimelanoma efficacy of 5-fluorouracil were investigated." | 7.81 | Topical Delivery of 5-Fluorouracil from Pheroid™ Formulations and the In Vitro Efficacy Against Human Melanoma. ( Chinembiri, TN; du Plessis, J; du Plessis, L; du Preez, J; Gerber, M, 2015) |
| " In this study, we tested antisense oligonucleotide inhibitors of FAK, in combination with 5-fluorouracil (5-FU), to increase its sensitivity in human melanoma cell lines." | 7.73 | Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell lines. ( Cance, WG; Golubovskaya, VM; Monia, BP; Peck, E; Smith, CS; Xu, LH; Yang, X, 2005) |
| " Although the two agents may interact in the biosynthetic pathway for thymidine, we investigated, as an alternative mechanism, the regulation of susceptibility of the A375 human melanoma to natural killers activated by interferon." | 7.68 | Abrogation of interferon-induced resistance to interferon-activated major histocompatibility complex-unrestricted killers by treatment of a melanoma cell line with 5-fluorouracil. ( Glass, J; Neefe, JR, 1991) |
| "We have observed differential effects of the cytotoxicity of 5-fluorouracil (5-FU) on human skin melanocytes and malignant melanoma cells in vitro." | 7.67 | Differential effects of 5-fluorouracil on human skin melanocytes and malignant melanoma cells in vitro. ( Karasek, MA; Tsuji, T, 1986) |
| " In the human melanoma cell lines IGR3 and M5 the main metabolite of 5FU was 5-fluorouridine, while in the murine B16 melanoma only a small amount of 5-fluorouridine was formed." | 7.67 | Separation of several 5-fluorouracil metabolites in various melanoma cell lines. Evidence for the synthesis of 5-fluorouracil-nucleotide sugars. ( Lankelma, J; Laurensse, E; Leyva, A; Peters, GJ; Pinedo, HM, 1984) |
| "5-Fluorouracil (5-FU) is an antimetabolite drug widely used for the treatment of skin cancer." | 5.72 | Controlled release of 5-fluorouracil to melanoma cells using a hydrogel/micelle composites based on deoxycholic acid and carboxymethyl chitosan. ( Behbood, L; Ebrahimi, S; Jalilian, F; Janfaza, S; Limoee, M; Pourmanouchehri, Z; Vosoughi, A, 2022) |
| "Metastatic skin lesions of gastric cancers usually appear as nonspecific, firm, and hyperpigmented nodules." | 5.51 | Appearance of cutaneous melanoma and subcutaneous metastases in metastatic gastric carcinoma undergoing chemotherapy with oral 5-fluorouracil prodrug. ( Covarelli, P; De Giorgi, V; Gori, A; Maida, P; Scarfì, F; Silvestri, F; Trane, L, 2019) |
| "Treatment of non melanoma skin cancer and its precancerous skin lesions is associated with severe topical and systemic toxicity." | 5.42 | Design, Development and Characterization of Topical Microemulsions of 5-Fluorouracil for the Treatment of Non Melanoma Skin Cancer and its Precursor Lesions. ( Kumar, S; Sinha, VR, 2015) |
| "Most importantly, 5-FU- or DTIC-treated melanoma cells also became sensitive to low-avidity CTL, which per se are less cytolytic to melanomas." | 5.32 | Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways. ( Haluska, FG; Yang, S, 2004) |
| "The lesions of 5 patients with multiple cutaneous metastases were treated topically, 5 days per week, with 5-fluorouracil in the morning and imiquimod at night." | 5.16 | Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil. ( Desmedt, E; Florin, V; Mortier, L; Vercambre-Darras, S, 2012) |
| "The mainstream treatments for non-melanoma skin cancer (NMSC) include photodynamic therapy (PDT), surgery excision (SE), cryotherapy (CT), imiquimod (IM), radiotherapy (RT), 5-fluorouracil (FU), and vehicle (VE)." | 4.95 | A Network Meta-Analysis of Non-Melanoma Skin Cancer (NMSC) Treatments: Efficacy and Safety Assessment. ( Lv, R; Sun, Q, 2017) |
| "This study examined the effects of folate environment of oligochitosan nanoparticles on their cellular internalization profiles in human melanoma cells." | 3.96 | Folate-induced nanostructural changes of oligochitosan nanoparticles and their fate of cellular internalization by melanoma. ( Kumar, P; Musalli, AH; Roy, P; Talukdar, PD; Wong, TW, 2020) |
| "5-Fluorouracil delivery profiles in the form of chitosan-folate submicron particles through skin and melanoma cells in vitro were examined using microwaves as the penetration enhancer." | 3.88 | Chitosan-Carboxymethyl-5-Fluorouracil-Folate Conjugate Particles: Microwave Modulated Uptake by Skin and Melanoma Cells. ( Nawaz, A; Wong, TW, 2018) |
| " However, little information is available concerning whether lidocaine sensitizes the cytotoxicity of 5-fluorouracil (5-FU) in melanoma cells." | 3.85 | Lidocaine sensitizes the cytotoxicity of 5-fluorouacil in melanoma cells ( Huang, S; Liu, W; Wang, Y; Xie, J; Xing, Y; Zhang, R, 2017) |
| "To assess whether multiple low doses of 5-fluorouracil could repress myeloid derived suppressor cells in low frequency and, in turn, could enhance anti-tumor responses and promote a more prolonged survival in a murine melanoma model." | 3.81 | Multiple Low Doses of 5-Fluorouracil Diminishes Immunosuppression by Myeloid Derived Suppressor Cells in Murine Melanoma Model. ( Ajami, M; Ashourpour, M; Hadjati, J; Jadidi-Niaragh, F; Mirzaei, HR; Namdar, A; Rezaei, A, 2015) |
| " In this study, the influence of Pheroid™ technology, which is a unique colloidal drug delivery system, on the skin permeation and antimelanoma efficacy of 5-fluorouracil were investigated." | 3.81 | Topical Delivery of 5-Fluorouracil from Pheroid™ Formulations and the In Vitro Efficacy Against Human Melanoma. ( Chinembiri, TN; du Plessis, J; du Plessis, L; du Preez, J; Gerber, M, 2015) |
| "A 59-year-old patient with a coexisting primary choroidal melanoma and colorectal cancer was treated with external beam radiation (EBR) of his choroidal melanoma and systemic chemotherapy with leukovorin/5 fluorouracil (FU) for treatment of his metastatic colorectal cancer." | 3.74 | Regression of radiation-induced macular edema after systemic bevacizumab. ( Bakri, SJ; Pulido, JS; Solano, JM, 2007) |
| " In this study, we tested antisense oligonucleotide inhibitors of FAK, in combination with 5-fluorouracil (5-FU), to increase its sensitivity in human melanoma cell lines." | 3.73 | Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell lines. ( Cance, WG; Golubovskaya, VM; Monia, BP; Peck, E; Smith, CS; Xu, LH; Yang, X, 2005) |
| "We pretreated cell lines derived from human melanomas, adenocarcinomas, and lymphomas with the PPIs omeprazole, esomeprazole, or pantoprazole and tested their response to cytotoxic drugs in cell death assays." | 3.72 | Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. ( Arancia, G; Belardelli, F; De Milito, A; Fais, S; Federici, C; Iessi, E; Logozzi, M; Lozupone, F; Luciani, F; Lugini, L; Marra, M; Molinari, A; Montinaro, A; Parmiani, G; Rivoltini, L; Spada, M, 2004) |
| " The aim of this study was to define the toxicity (animal lethality) and the activity (growth delay assay, excision assay) of a bioreductive drug, tirapazamine, alone and combined with chemotherapy agents (5-FU, VP16, bleo, DTIC and c-DDP) on nude mice bearing xenografted human tumours: a rectal carcinoma (HRT18) and a melanoma (Na11+)." | 3.69 | The effect of tirapazamine (SR-4233) alone or combined with chemotherapeutic agents on xenografted human tumours. ( Guichard, M; Lartigau, E, 1996) |
| " Although the two agents may interact in the biosynthetic pathway for thymidine, we investigated, as an alternative mechanism, the regulation of susceptibility of the A375 human melanoma to natural killers activated by interferon." | 3.68 | Abrogation of interferon-induced resistance to interferon-activated major histocompatibility complex-unrestricted killers by treatment of a melanoma cell line with 5-fluorouracil. ( Glass, J; Neefe, JR, 1991) |
| " In the human melanoma cell lines IGR3 and M5 the main metabolite of 5FU was 5-fluorouridine, while in the murine B16 melanoma only a small amount of 5-fluorouridine was formed." | 3.67 | Separation of several 5-fluorouracil metabolites in various melanoma cell lines. Evidence for the synthesis of 5-fluorouracil-nucleotide sugars. ( Lankelma, J; Laurensse, E; Leyva, A; Peters, GJ; Pinedo, HM, 1984) |
| "Different methods were compared for the in vitro evaluation of the therapeutic effects of the antineoplastic agents doxorubicin, cisplatin, fluorouracil, and vinblastine sulfate in a model system of murine tumor cell lines consisting of L1210 leukemia, P815 mast cell leukemia, and B16 melanoma." | 3.67 | In vitro assessment of cytotoxic agents in murine cancers: comparison between antiproliferative and antimetabolic assays. ( Atassi, G; Bernheim, JL; Roobol, C; Sips, HC; Theunissen, J, 1984) |
| "We have observed differential effects of the cytotoxicity of 5-fluorouracil (5-FU) on human skin melanocytes and malignant melanoma cells in vitro." | 3.67 | Differential effects of 5-fluorouracil on human skin melanocytes and malignant melanoma cells in vitro. ( Karasek, MA; Tsuji, T, 1986) |
| "We examined the ability of uridine to increase the therapeutic index of 5-fluorouracil (FUra) against C57BL/6 X DBA/2 F1 mice bearing a Day 1 B16 melanoma or L1210 leukemia." | 3.66 | Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil. ( Cerna, I; Klubes, P, 1983) |
| "Lambdamycin, a chromoglycoside antibiotic like chartreusin was found to be very active against leukemias L 1210 and P 388 and moderate effective against melanoma B 16 and Lewis lung carcinoma of mice." | 3.66 | [Antineoplastic activity of lambdamycin in different murine test models compared with cyclophosphamide, 6-mercaptopurine and 5-fluorouracil (author's transl)]. ( Fleck, WF; Gutsche, W; Jungstand, W; Wohlrabe, K, 1981) |
| " Adenocarcinoma related to diethylstilbestrol exposure in utero is a recently recognized type of vaginal lesion, and melanoma and sarcoma occur rarely in the vagina." | 3.66 | Malignant tumors of the vagina. Classification and approach to treatment. ( Gerbie, MV, 1983) |
| "A comparison has been made between the cloning capacity and changes in tritiated deoxyuridine (6-[3H]-UdR) incorporation of L1210 (murine leukaemia) and PMC-22 (human melanoma) cells treated with methotrexate (MTX), 5-fluorouracil (5-FU) and cytosine arabinoside (ARA-C)." | 3.66 | Assessment of antimetabolite cytotoxicity: a comparison of clonogenic assays and tritiated deoxyuridine incorporation. ( Perez, DJ; Tattersall, MH, 1983) |
| " Results of treatment of B16 melanoma and Lewis lung carcinoma with 3,4-dihydroxybenzohydroxamic acid are used to demonstrate this definition." | 3.66 | Drug activity and therapeutic synergism in cancer treatment. ( Campbell, ED; Carter, WH; Stablein, DM; Wampler, GL, 1982) |
| "The extent of tumour, cell kill, produced by treating B16 melanomas with vincristine, cyclophosphamide, 5-fluorouracil and gamma-rays, alone and in combination, was determined using an in vitro colony assay." | 3.65 | Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation. ( Peacock, JH; Steel, GG; Stephens, TC, 1977) |
| "The effects of single agent therapy with 1-(-chloroethyl)-3-cyclohexyl-1-nitrosourea, 5-fluorouracil, and 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide on a human malignant melanoma transplanted and passed serially in thymusless nude mouse were studied." | 3.65 | Chemotherapy of a human malignant melanoma transplanted in the nude mouse. ( Jacobsen, GK; Povlsen, CO, 1975) |
| "Response to anticancer therapy is believed to be directly related to the concentration of the anticancer drug in the tumor itself." | 2.76 | Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study. ( de Bruijn, P; Ghobadi Moghaddam-Helmantel, IM; Konings, IR; Loos, WJ; Mathijssen, RH; Sleijfer, S; van Dam, LM; Verweij, J; Wiemer, EA, 2011) |
| "Topical treatment of skin cancer may therefore be more appropriate in certain instances." | 2.66 | Topical treatments for skin cancer. ( Boyle, GM; Cullen, JK; Parsons, PG; Simmons, JL, 2020) |
| "Skin cancer is a high burden disease with a high impact on global health." | 2.66 | Nanotechnology approaches in the current therapy of skin cancer. ( Bentley, MVLB; Borgheti-Cardoso, LN; Caron, AL; Kravicz, M; Praça, FG; Silvestrini, AVP; Viegas, JSR, 2020) |
| "Antibody against a breast carcinoma antigen was present in patients with breast carcinoma and other cancer more often (P less than ." | 2.64 | Immunology and adjuvant chemoimmunotherapy of breast cancer. ( Morton, DL; Ramming, KP; Silver, HK; Sparks, FC; Wile, AG; Wolk, RW, 1976) |
| "With regard to squamous cell carcinoma, treatment with 5-fluorouracil, methotrexate, interferon, and bleomycin are reviewed." | 2.47 | Intralesional agents in the management of cutaneous malignancy: a review. ( Good, LM; High, WA; Miller, MD, 2011) |
| "Five-year survival rates were 57% for squamous cell carcinoma, 63% for adenocarcinoma, and 33% for melanoma." | 2.40 | Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes. ( Klas, JV; Madoff, RD; Rothenberger, DA; Wong, WD, 1999) |
| "The pharmacokinetic advantage of a novel system to noninvasively isolate the hepatic venous outflow and infuse high doses of chemotherapy (doxorubicin or 5-FU) is discussed and compared with intravenous infusion and intra-arterial infusion without hepatic venous detoxification." | 2.39 | Isolated liver perfusion for liver metastases: pharmacokinetic advantage? ( Dixon, K; Ravikumar, TS, 1996) |
| "Melanoma is a disease that need not be deadly." | 2.38 | The prevention of cutaneous malignant melanoma: high-risk groups, chemoprevention, education, and screening. ( Greene, MH, 1993) |
| "These neurologic disorders can be either metastatic to the brain, spinal cord, leptomeninges, or peripheral nerves or nonmetastatic including infections, vascular problems, metabolic abnormalities, side effects of therapy, or paraneoplastic syndromes." | 2.37 | Neurologic complications of systemic cancer. ( Patchell, RA; Posner, JB, 1985) |
| "The potential impact on cancer mortality from these treatment results is obvious." | 2.36 | Multimodal primary cancer treatment (adjuvant chemotherapy): current results and future prospects. ( DeVita, VT; Weiss, RB, 1979) |
| "5-Fluorouracil (5-FU) is an antimetabolite drug widely used for the treatment of skin cancer." | 1.72 | Controlled release of 5-fluorouracil to melanoma cells using a hydrogel/micelle composites based on deoxycholic acid and carboxymethyl chitosan. ( Behbood, L; Ebrahimi, S; Jalilian, F; Janfaza, S; Limoee, M; Pourmanouchehri, Z; Vosoughi, A, 2022) |
| "5-Fluorouracil treatment also accelerated the expression of the pro-apoptotic protein BAX and decelerated the expression of the anti-apoptotic protein Bcl-xL on melanoma cell line." | 1.51 | A Potential Therapy Using Engineered Stem Cells Prevented Malignant Melanoma in Cellular and Xenograft Mouse Models. ( Choi, KC; Heo, JR; Hwang, KA; Kim, SU, 2019) |
| "Metastatic skin lesions of gastric cancers usually appear as nonspecific, firm, and hyperpigmented nodules." | 1.51 | Appearance of cutaneous melanoma and subcutaneous metastases in metastatic gastric carcinoma undergoing chemotherapy with oral 5-fluorouracil prodrug. ( Covarelli, P; De Giorgi, V; Gori, A; Maida, P; Scarfì, F; Silvestri, F; Trane, L, 2019) |
| "Treatment of non melanoma skin cancer and its precancerous skin lesions is associated with severe topical and systemic toxicity." | 1.42 | Design, Development and Characterization of Topical Microemulsions of 5-Fluorouracil for the Treatment of Non Melanoma Skin Cancer and its Precursor Lesions. ( Kumar, S; Sinha, VR, 2015) |
| "Apigenin has an antioxidant capacity as well as the ability to inhibit lipid peroxidation." | 1.38 | Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin. ( Chan, LP; Chen, PR; Chiang, FY; Chou, TH; Ding, HY; Kuo, PL; Liang, CH, 2012) |
| "Twenty-five squamous cell carcinomas, 1 melanoma, 2 basocellular carcinomas and 2 adenoid cystic carcinomas were treated." | 1.33 | [The outcome of treatments for carcinoma of the external auditory canal]. ( Delalande, C; Dumas, G; Lavieille, JP; Reyt, E; Righini, Ch; Schmerber, S; Soriano, E, 2005) |
| "Most importantly, 5-FU- or DTIC-treated melanoma cells also became sensitive to low-avidity CTL, which per se are less cytolytic to melanomas." | 1.32 | Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways. ( Haluska, FG; Yang, S, 2004) |
| "Patients diagnosed with Chronic Lymphocytic Leukemia (CLL) have an increased risk of developing second primary cancers." | 1.31 | Multiple neoplasms: a case report. ( Pigeaud-Klessens, ML; van der Valk, P, 2002) |
| "Melanoma has proven to be resistant to conventional chemotherapy; however,the mechanism of chemoresistance is still unclear." | 1.31 | Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors. ( Dong, YB; Elliott, MJ; McMasters, KM; Yang, HL, 2002) |
| "The major limitation in the treatment of malignant melanoma is the lack of availability of effective agents for treatment." | 1.29 | Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity. ( Algermissen, B; Czarnetzki, BM; Kohlmus, CM; Schadendorf, D; Worm, M, 1994) |
| "Levamisole is an effective antihelminthic drug with immunomodulatory and anticancer activities in model systems." | 1.28 | Levamisole potentiation of fluorouracil antiproliferative activity mimicked by orthovanadate, an inhibitor of tyrosine phosphatase. ( Kovach, JS; Schaid, DJ; Svingen, PA, 1992) |
| "Human hepatoma and melanoma tumor cells and normal melanocytes, keratinocytes, and fibroblasts were incubated for 2, 24, and 48 h with graded concentrations of cis-platinum (0." | 1.28 | Rapid chemosensitivity assay with human normal and tumor cells in vitro. ( Babich, H; Borenfreund, E; Martin-Alguacil, N, 1990) |
| "Tumor metastasis was examined after iv inoculation of highly metastatic variants of mouse tumors." | 1.27 | Metastasis after intravenous inoculation of highly metastatic variants of mouse tumors and the effects of several antitumor drugs on the tumors. ( Hori, K; Kawabata, H; Naganuma, K; Sakurai, Y; Tsukagoshi, S; Tsuruo, T; Yamori, T, 1984) |
| "Spontaneous metastasis of highly metastatic variants, B16 melanoma BL-6 and colon adenocarcinoma 26 NL-22, was examined." | 1.27 | Spontaneous metastasis of highly metastatic variants of mouse tumors and the effect of drugs on the metastasis. ( Iida, H; Kawabata, H; Naganuma, K; Oh-Hara, T; Sakurai, Y; Tsukagoshi, S; Tsuruo, T; Yamori, T, 1984) |
| " Our results show that all five drugs exhibited a dose-response relationship against tumor cells and GM-CFUC." | 1.27 | Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro. ( Ajani, JA; Baker, FL; Blaauw, AA; Dicke, KA; Spitzer, G; Thielvoldt, D; Tomasovic, B; Umbach, G; Zander, AR, 1985) |
| "Vitiligo is characterized by depigmentation in large or small areas of the skin." | 1.27 | Vitiligo. ( Dunn, JF, 1986) |
| "Human malignant melanoma was transplanted to the cheek pouch of immunosuppressed (corticosteroid-treated) hamsters." | 1.26 | Chemotherapy against human melanoma in the hamster cheek pouch. ( Dufour, FD; Mah, SG; Morton, DL; Okada, GT, 1980) |
| "Six of the patients' dysplastic melanocytic nevi were treated with topical fluorouracil." | 1.26 | Topical chemotherapy of dysplastic melanocytic nevi with 5% fluorouracil. ( Bondi, EE; Clark, WH; Elder, D; Greene, MH; Guerry, D, 1981) |
| "Generally, metastases responded better than the advanced primaries from which they were derived, except for those from breast tumours." | 1.25 | The influence of site of metastasis on tumour growth and response to chemotherapy. ( Bross, ID; Slack, NH, 1975) |
| "All 14 patients with breast carcinoma underwent remission and in 6 this was complete." | 1.25 | Seventy-five cases of solid tumours treated by a modified quadruple chemotherapy regime. ( Hanham, IW; Newton, KA; Westbury, G, 1971) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 114 (56.44) | 18.7374 |
| 1990's | 20 (9.90) | 18.2507 |
| 2000's | 20 (9.90) | 29.6817 |
| 2010's | 36 (17.82) | 24.3611 |
| 2020's | 12 (5.94) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, KH | 1 |
| Wu, YS | 1 |
| Hall, IH | 1 |
| Tran, QL | 1 |
| Tezuka, Y | 1 |
| Banskota, AH | 1 |
| Tran, QK | 1 |
| Saiki, I | 1 |
| Kadota, S | 1 |
| Pourmanouchehri, Z | 1 |
| Ebrahimi, S | 1 |
| Limoee, M | 1 |
| Jalilian, F | 1 |
| Janfaza, S | 1 |
| Vosoughi, A | 1 |
| Behbood, L | 1 |
| Rahbar, S | 1 |
| Shafiekhani, S | 1 |
| Allahverdi, A | 1 |
| Jamali, A | 1 |
| Kheshtchin, N | 2 |
| Ajami, M | 2 |
| Mirsanei, Z | 1 |
| Habibi, S | 1 |
| Makkiabadi, B | 1 |
| Hadjati, J | 3 |
| Jafari, AH | 1 |
| Matadh, AV | 3 |
| Jakka, D | 3 |
| Pragathi, SG | 3 |
| Rangappa, S | 3 |
| Shivakumar, HN | 3 |
| Maibach, H | 3 |
| Reena, NM | 3 |
| Murthy, SN | 3 |
| Ali, A | 1 |
| Madni, A | 1 |
| Shah, H | 1 |
| Jamshaid, T | 1 |
| Jan, N | 1 |
| Khan, S | 1 |
| Khan, MM | 1 |
| Mahmood, MA | 1 |
| Jakubechova, J | 1 |
| Smolkova, B | 1 |
| Furdova, A | 1 |
| Demkova, L | 1 |
| Altanerova, U | 1 |
| Nicodemou, A | 1 |
| Zeleznikova, T | 1 |
| Klimova, D | 1 |
| Altaner, C | 1 |
| Zhang, L | 1 |
| Ji, Z | 1 |
| Zhang, J | 2 |
| Yang, S | 2 |
| De Giorgi, V | 1 |
| Scarfì, F | 1 |
| Trane, L | 1 |
| Silvestri, F | 1 |
| Maida, P | 1 |
| Gori, A | 1 |
| Covarelli, P | 1 |
| Cullen, JK | 1 |
| Simmons, JL | 1 |
| Parsons, PG | 1 |
| Boyle, GM | 1 |
| Borgheti-Cardoso, LN | 1 |
| Viegas, JSR | 1 |
| Silvestrini, AVP | 1 |
| Caron, AL | 1 |
| Praça, FG | 1 |
| Kravicz, M | 1 |
| Bentley, MVLB | 1 |
| Musalli, AH | 1 |
| Talukdar, PD | 1 |
| Roy, P | 1 |
| Kumar, P | 1 |
| Wong, TW | 3 |
| Yaman, Ü | 1 |
| Aslan, M | 1 |
| Ozturk, S | 1 |
| Ulubayram, K | 1 |
| Eroğlu, İ | 1 |
| Liu, S | 1 |
| Fang, S | 1 |
| Su, X | 1 |
| Zhang, Q | 1 |
| Zhu, G | 1 |
| Zhu, L | 1 |
| Zhao, M | 1 |
| Liu, F | 1 |
| Luo, Y | 1 |
| Pei, S | 1 |
| Xu, J | 1 |
| Xiao, Y | 1 |
| Zhu, X | 1 |
| Malvi, P | 1 |
| Janostiak, R | 1 |
| Nagarajan, A | 1 |
| Zhang, X | 2 |
| Wajapeyee, N | 1 |
| Lv, R | 1 |
| Sun, Q | 1 |
| Haeusler, KA | 1 |
| Hall, JR | 1 |
| Seykora, CM | 1 |
| Abuzeid, MJ | 1 |
| Dalton, SR | 1 |
| Calienni, MN | 1 |
| Temprana, CF | 1 |
| Prieto, MJ | 1 |
| Paolino, D | 1 |
| Fresta, M | 1 |
| Tekinay, AB | 1 |
| Alonso, SDV | 1 |
| Montanari, J | 1 |
| Khan, NR | 1 |
| Wang, Y | 1 |
| Xie, J | 1 |
| Liu, W | 2 |
| Zhang, R | 1 |
| Huang, S | 1 |
| Xing, Y | 1 |
| Khosravianfar, N | 1 |
| Namdar, A | 2 |
| Boghozian, R | 1 |
| Hafezi, M | 1 |
| Ashourpour, M | 2 |
| Banitalebi, M | 1 |
| Mirzaei, R | 1 |
| Razavi, SA | 1 |
| Lori, G | 1 |
| Paoli, P | 1 |
| Caselli, A | 1 |
| Cirri, P | 1 |
| Marzocchini, R | 1 |
| Mangoni, M | 1 |
| Talamonti, C | 1 |
| Livi, L | 1 |
| Raugei, G | 1 |
| Nawaz, A | 1 |
| Heo, JR | 1 |
| Hwang, KA | 1 |
| Kim, SU | 1 |
| Choi, KC | 1 |
| Sahu, P | 1 |
| Kashaw, SK | 1 |
| Sau, S | 1 |
| Kushwah, V | 1 |
| Jain, S | 1 |
| Agrawal, RK | 1 |
| Iyer, AK | 1 |
| Voiculescu, VM | 1 |
| Lisievici, CV | 1 |
| Lupu, M | 1 |
| Vajaitu, C | 1 |
| Draghici, CC | 1 |
| Popa, AV | 1 |
| Solomon, I | 1 |
| Sebe, TI | 1 |
| Constantin, MM | 1 |
| Caruntu, C | 1 |
| Lyons, AB | 1 |
| Mitchell, DA | 1 |
| Moy, RL | 1 |
| Quigley, EA | 1 |
| Halpern, AC | 1 |
| LaPresto, L | 1 |
| Cranmer, L | 1 |
| Morrison, L | 1 |
| Erickson, CP | 1 |
| Curiel-Lewandrowski, C | 1 |
| Shakeel, F | 1 |
| Haq, N | 1 |
| Al-Dhfyan, A | 1 |
| Alanazi, FK | 1 |
| Alsarra, IA | 1 |
| Péguillet, I | 1 |
| Milder, M | 1 |
| Louis, D | 1 |
| Vincent-Salomon, A | 1 |
| Dorval, T | 1 |
| Piperno-Neumann, S | 1 |
| Scholl, SM | 1 |
| Lantz, O | 1 |
| Chen, L | 1 |
| Gong, MW | 1 |
| Peng, ZF | 1 |
| Zhou, T | 1 |
| Ying, MG | 1 |
| Zheng, QH | 1 |
| Liu, QY | 1 |
| Zhang, QQ | 1 |
| Grey, A | 1 |
| Cooper, A | 1 |
| McNeil, C | 1 |
| O'Toole, S | 1 |
| Thompson, J | 1 |
| Grimison, P | 1 |
| Wu, CF | 1 |
| Wu, CS | 1 |
| Yu, WW | 1 |
| Huang, MY | 1 |
| Rosa, A | 1 |
| Nieddu, M | 1 |
| Piras, A | 1 |
| Atzeri, A | 1 |
| Putzu, D | 1 |
| Rescigno, A | 1 |
| Chinembiri, TN | 1 |
| Gerber, M | 1 |
| du Plessis, L | 1 |
| du Preez, J | 1 |
| du Plessis, J | 1 |
| Kumar, S | 1 |
| Sinha, VR | 1 |
| Mirzaei, HR | 1 |
| Jadidi-Niaragh, F | 1 |
| Rezaei, A | 1 |
| Kudriavtsev, DV | 1 |
| Kudriavtseva, GT | 1 |
| Mardynskiĭ, IuS | 1 |
| Tay, E | 1 |
| Cree, IA | 1 |
| Hungerford, J | 1 |
| Franks, W | 1 |
| Good, LM | 1 |
| Miller, MD | 1 |
| High, WA | 1 |
| Troisi, RI | 1 |
| Van Huysse, J | 1 |
| Berrevoet, F | 1 |
| Vandenbossche, B | 1 |
| Sainz-Barriga, M | 1 |
| Vinci, A | 1 |
| Ricciardi, S | 1 |
| Bocchetti, T | 1 |
| Rogiers, X | 1 |
| de Hemptinne, B | 1 |
| Konings, IR | 1 |
| Sleijfer, S | 1 |
| Mathijssen, RH | 1 |
| de Bruijn, P | 1 |
| Ghobadi Moghaddam-Helmantel, IM | 1 |
| van Dam, LM | 1 |
| Wiemer, EA | 1 |
| Verweij, J | 1 |
| Loos, WJ | 1 |
| Kundu, S | 1 |
| Fan, K | 1 |
| Cao, M | 1 |
| Lindner, DJ | 1 |
| Tuthill, R | 1 |
| Liu, L | 1 |
| Gerson, S | 1 |
| Borden, E | 1 |
| Yi, T | 1 |
| Black, JM | 1 |
| Hodari, KT | 1 |
| Rogers, N | 1 |
| Farris, PK | 1 |
| Lewis, AT | 1 |
| Boh, EE | 1 |
| Florin, V | 1 |
| Desmedt, E | 1 |
| Vercambre-Darras, S | 1 |
| Mortier, L | 1 |
| Chan, LP | 1 |
| Chou, TH | 1 |
| Ding, HY | 1 |
| Chen, PR | 1 |
| Chiang, FY | 1 |
| Kuo, PL | 1 |
| Liang, CH | 1 |
| Li, X | 1 |
| Wong, YS | 1 |
| Zheng, W | 1 |
| Zhang, Y | 1 |
| Cao, W | 1 |
| Chen, T | 1 |
| Viros, A | 1 |
| Hayward, R | 1 |
| Martin, M | 1 |
| Yashar, S | 1 |
| Yu, CC | 1 |
| Sanchez-Laorden, B | 1 |
| Zambon, A | 1 |
| Niculescu-Duvaz, D | 1 |
| Springer, C | 1 |
| Lo, RS | 1 |
| Marais, R | 1 |
| Fang, P | 1 |
| Gao, Y | 1 |
| Ding, CR | 1 |
| Cui, F | 1 |
| Jiao, SC | 1 |
| Fathi, R | 1 |
| Kamalpour, L | 1 |
| Gammon, B | 1 |
| Tung, R | 1 |
| Bogenrieder, T | 1 |
| Weitzel, C | 1 |
| Schölmerich, J | 1 |
| Landthaler, M | 1 |
| Stolz, W | 1 |
| Fei, XF | 1 |
| Wang, BX | 1 |
| Li, TJ | 1 |
| Tashiro, S | 1 |
| Minami, M | 1 |
| Xing, DJ | 1 |
| Ikejima, T | 1 |
| BRINDLEY, CO | 1 |
| REITEMEIER, RJ | 1 |
| MOERTEL, CG | 1 |
| BLACKBURN, CM | 1 |
| MOORE, JG | 1 |
| VANCAMPENHOUT, JL | 1 |
| BRANDKAMP, WW | 1 |
| COBB, JP | 1 |
| WALKER, DG | 1 |
| DOWD, JE | 1 |
| DIPAOLO, JA | 1 |
| WATNE, AL | 1 |
| SULLIVAN, RD | 1 |
| ZUREK, WZ | 1 |
| KINSEY, DL | 1 |
| LINDEBOOM, GA | 1 |
| CRESSY, NL | 1 |
| SCHELL, HW | 1 |
| Dummer, R | 1 |
| Beyeler, M | 1 |
| Morcinek, J | 1 |
| Burg, G | 1 |
| Haluska, FG | 1 |
| Fukushima, S | 1 |
| Hatta, N | 1 |
| Luciani, F | 1 |
| Spada, M | 1 |
| De Milito, A | 1 |
| Molinari, A | 1 |
| Rivoltini, L | 1 |
| Montinaro, A | 1 |
| Marra, M | 1 |
| Lugini, L | 1 |
| Logozzi, M | 1 |
| Lozupone, F | 1 |
| Federici, C | 1 |
| Iessi, E | 1 |
| Parmiani, G | 1 |
| Arancia, G | 1 |
| Belardelli, F | 1 |
| Fais, S | 1 |
| Patonay, P | 1 |
| Naszály, A | 1 |
| Mayer, A | 1 |
| Pócza, K | 1 |
| Kovács, L | 1 |
| Smith, CS | 1 |
| Golubovskaya, VM | 1 |
| Peck, E | 1 |
| Xu, LH | 1 |
| Monia, BP | 1 |
| Yang, X | 1 |
| Cance, WG | 1 |
| Schmerber, S | 1 |
| Righini, Ch | 1 |
| Soriano, E | 1 |
| Delalande, C | 1 |
| Dumas, G | 1 |
| Reyt, E | 1 |
| Lavieille, JP | 1 |
| Zhang, C | 1 |
| Beckermann, B | 1 |
| Kallifatidis, G | 1 |
| Liu, Z | 1 |
| Rittgen, W | 1 |
| Edler, L | 1 |
| Büchler, P | 1 |
| Debatin, KM | 1 |
| Büchler, MW | 1 |
| Friess, H | 1 |
| Herr, I | 1 |
| Resnik, KS | 1 |
| DiLeonardo, M | 1 |
| Gibbons, G | 1 |
| Benassi, B | 1 |
| Zupi, G | 1 |
| Biroccio, A | 1 |
| Solano, JM | 1 |
| Bakri, SJ | 1 |
| Pulido, JS | 1 |
| Zamboni, S | 1 |
| Mallano, A | 1 |
| Flego, M | 1 |
| Ascione, A | 1 |
| Dupuis, ML | 1 |
| Gellini, M | 1 |
| Barca, S | 1 |
| Cianfriglia, M | 1 |
| Stehlin, JS | 2 |
| Hills, WJ | 1 |
| Rufino, C | 1 |
| Markman, M | 1 |
| Oberfield, RA | 3 |
| Kemeny, N | 1 |
| Ninomiya, K | 1 |
| Sekido, S | 1 |
| Araki, T | 1 |
| Pedersen, JE | 1 |
| Barron, G | 1 |
| Nosoh, Y | 1 |
| Yoshinaka, K | 1 |
| Yamaguchi, M | 1 |
| Tani, T | 1 |
| Toge, T | 1 |
| Niimoto, M | 1 |
| Hattori, T | 1 |
| Tsuruo, T | 2 |
| Naganuma, K | 2 |
| Yamori, T | 2 |
| Kawabata, H | 2 |
| Oh-Hara, T | 1 |
| Iida, H | 1 |
| Tsukagoshi, S | 2 |
| Sakurai, Y | 2 |
| Peters, GJ | 1 |
| Laurensse, E | 1 |
| Lankelma, J | 1 |
| Leyva, A | 1 |
| Pinedo, HM | 1 |
| Roobol, C | 1 |
| Sips, HC | 1 |
| Theunissen, J | 1 |
| Atassi, G | 1 |
| Bernheim, JL | 1 |
| Gerbie, MV | 1 |
| Perez, DJ | 1 |
| Tattersall, MH | 1 |
| Hori, K | 1 |
| Hofer, D | 2 |
| Dubitsky, AM | 1 |
| Reïlly, P | 2 |
| Santoro, MG | 2 |
| Jaffe, BM | 2 |
| Vrba, M | 1 |
| Adámek, R | 1 |
| Blasko, M | 1 |
| Brezina, V | 1 |
| Chrz, R | 1 |
| Goetz, P | 1 |
| Michalová, K | 1 |
| Musilová, J | 1 |
| Novotná, B | 1 |
| Pogosianz, HE | 1 |
| Raposa, T | 1 |
| Siracký, J | 1 |
| Sokova, OI | 1 |
| Thust, R | 1 |
| Ujházy, V | 1 |
| Volgareva, GM | 1 |
| Dubitsky, A | 1 |
| Marti, J | 1 |
| Carter, WH | 1 |
| Wampler, GL | 1 |
| Stablein, DM | 1 |
| Campbell, ED | 1 |
| Klubes, P | 1 |
| Cerna, I | 1 |
| Erlichman, C | 1 |
| Donehower, RC | 1 |
| Speyer, JL | 1 |
| Klecker, R | 1 |
| Chabner, BA | 1 |
| Citarella, RV | 1 |
| Wallace, RE | 1 |
| Murdock, KC | 1 |
| Angier, RB | 1 |
| Durr, FE | 1 |
| Forbes, M | 1 |
| Sacks, H | 1 |
| Chalmers, TC | 1 |
| Smith, H | 1 |
| Finck, SJ | 1 |
| Gupta, RK | 1 |
| Giuliano, AE | 1 |
| Morton, DL | 3 |
| Nakashima, T | 1 |
| Matsumura, Y | 1 |
| Nomura, Y | 1 |
| Komiyama, S | 1 |
| Makishima, K | 1 |
| Hiroto, I | 1 |
| Gutsche, W | 1 |
| Wohlrabe, K | 1 |
| Jungstand, W | 1 |
| Fleck, WF | 1 |
| Richter, P | 1 |
| Sarembe, B | 1 |
| Geissler, U | 1 |
| Dufour, FD | 1 |
| Okada, GT | 1 |
| Mah, SG | 1 |
| Bondi, EE | 1 |
| Clark, WH | 1 |
| Elder, D | 1 |
| Guerry, D | 1 |
| Greene, MH | 2 |
| Schadendorf, D | 1 |
| Worm, M | 1 |
| Algermissen, B | 1 |
| Kohlmus, CM | 1 |
| Czarnetzki, BM | 1 |
| Turk, PS | 1 |
| Belliveau, JF | 1 |
| Darnowski, JW | 1 |
| Weinberg, MC | 1 |
| Leenen, L | 1 |
| Wanebo, HJ | 1 |
| Chandrasekaran, B | 1 |
| Kute, TE | 1 |
| Duch, DS | 1 |
| Phuphanich, S | 1 |
| Jacobs, M | 1 |
| Spiers, A | 1 |
| Lartigau, E | 1 |
| Guichard, M | 1 |
| Gutman, M | 2 |
| Abu-Abid, S | 1 |
| Sorkine, P | 1 |
| Inbar, M | 2 |
| Lev, D | 1 |
| Chen, Z | 1 |
| Oron, D | 1 |
| Chaitchik, S | 2 |
| Klausner, JM | 2 |
| Ravikumar, TS | 1 |
| Dixon, K | 1 |
| Szala, S | 1 |
| Missol, E | 1 |
| Sochanik, A | 1 |
| Strozyk, M | 1 |
| Walpole, ET | 1 |
| Hersey, P | 1 |
| Thomson, D | 1 |
| McLeod, GR | 1 |
| Négrier, S | 1 |
| Klas, JV | 1 |
| Rothenberger, DA | 1 |
| Wong, WD | 1 |
| Madoff, RD | 1 |
| Pletnev, SD | 1 |
| Dong, YB | 1 |
| Yang, HL | 1 |
| Elliott, MJ | 1 |
| McMasters, KM | 1 |
| Pigeaud-Klessens, ML | 1 |
| van der Valk, P | 1 |
| Cohen, SC | 1 |
| Gabelnick, HL | 1 |
| Johnson, RK | 2 |
| Goldin, A | 2 |
| Schneider, I | 1 |
| Aulepp, H | 1 |
| Gartmann, H | 1 |
| Mabel, JA | 1 |
| Merker, PC | 1 |
| Sturgeon, ML | 1 |
| Wodinsky, I | 1 |
| Geran, RI | 1 |
| Dunnick, NR | 1 |
| Jones, RB | 1 |
| Doppman, JL | 1 |
| Speyer, J | 1 |
| Myers, CE | 1 |
| Volm, M | 2 |
| Faufmann, M | 1 |
| MAttern, J | 2 |
| Wayss, K | 2 |
| Gough, IR | 1 |
| Bolton, PM | 1 |
| Clunie, GJ | 1 |
| Burnett, W | 1 |
| Weiss, RB | 1 |
| DeVita, VT | 1 |
| Jones, KD | 1 |
| Hughes, LE | 1 |
| Honn, KV | 1 |
| Dunn, JR | 1 |
| Morgan, LR | 1 |
| Bienkowski, M | 1 |
| Marnett, LJ | 1 |
| Kuriya, Y | 1 |
| Nishihira, T | 1 |
| Mori, S | 1 |
| Watanabe, T | 1 |
| Kasai, M | 1 |
| Nordman, EM | 1 |
| Mäntylä, M | 1 |
| Garibjanian, BT | 1 |
| Kline, I | 1 |
| Vadlamudi, S | 1 |
| Gang, M | 1 |
| Venditti, JM | 1 |
| Berry, RJ | 1 |
| Laing, AH | 1 |
| Wells, J | 1 |
| Hill, GJ | 2 |
| Johnson, RO | 1 |
| Metter, G | 1 |
| Wilson, WL | 1 |
| Davis, HL | 1 |
| Grage, T | 1 |
| Fletcher, WS | 2 |
| Golomb, FM | 1 |
| Cruz, AB | 2 |
| Stephens, TC | 1 |
| Peacock, JH | 1 |
| Steel, GG | 1 |
| Bergman, RB | 1 |
| Sparks, FC | 1 |
| Wile, AG | 1 |
| Ramming, KP | 1 |
| Silver, HK | 1 |
| Wolk, RW | 1 |
| Young, RC | 1 |
| Gutterman, JU | 1 |
| Mavligit, GM | 1 |
| Blumenshein, G | 1 |
| Burgess, MA | 1 |
| McBride, CM | 2 |
| Hersh, EM | 1 |
| Dowell, KE | 1 |
| Armstrong, DM | 1 |
| Aust, JB | 1 |
| Povlsen, CO | 1 |
| Jacobsen, GK | 1 |
| Slack, NH | 1 |
| Bross, ID | 1 |
| Golematis, BC | 1 |
| Delikaris, PG | 1 |
| Haritopoulos, NK | 1 |
| Setakis, NG | 1 |
| Kovach, JS | 1 |
| Svingen, PA | 1 |
| Schaid, DJ | 1 |
| Olver, IN | 1 |
| Bishop, JF | 1 |
| Green, M | 1 |
| Zimet, A | 1 |
| Laidlaw, C | 1 |
| Gazit, Z | 1 |
| Weiss, DW | 1 |
| Shouval, D | 1 |
| Yechezkeli, M | 1 |
| Schirrmacher, V | 1 |
| Notter, M | 1 |
| Walter, J | 1 |
| Kedar, E | 1 |
| Mulder, NH | 1 |
| de Vries, EG | 1 |
| Sleijfer, DT | 1 |
| Schraffordt Koops, H | 1 |
| Willemse, PH | 1 |
| Neefe, JR | 1 |
| Glass, J | 1 |
| Tsao, SW | 1 |
| Ng, TB | 1 |
| Yeung, HW | 1 |
| Borenfreund, E | 1 |
| Babich, H | 1 |
| Martin-Alguacil, N | 1 |
| Barth, V | 1 |
| Schönfelder, M | 1 |
| Tsuji, T | 1 |
| Karasek, MA | 1 |
| Rozin, RR | 1 |
| Lelcuk, S | 1 |
| Ajani, JA | 1 |
| Blaauw, AA | 1 |
| Spitzer, G | 1 |
| Baker, FL | 1 |
| Tomasovic, B | 1 |
| Umbach, G | 1 |
| Thielvoldt, D | 1 |
| Zander, AR | 1 |
| Dicke, KA | 1 |
| Wang, QL | 1 |
| Ryan, RF | 1 |
| Krementz, ET | 2 |
| Litwin, MS | 1 |
| Pályi, I | 1 |
| Keppler, BK | 1 |
| Rupp, W | 1 |
| Dunn, JF | 1 |
| Ashman, CR | 1 |
| Kaufman, ER | 1 |
| Davidson, RL | 1 |
| Patchell, RA | 1 |
| Posner, JB | 1 |
| Fuller, AF | 1 |
| Krane, IM | 1 |
| Budzik, GP | 1 |
| Donahoe, PK | 1 |
| Leidi, L | 1 |
| Maina, G | 1 |
| Rappelli, F | 1 |
| Cocola, L | 1 |
| Durando, C | 1 |
| Gary-Bobo, J | 1 |
| Richard, JM | 1 |
| Sancho, H | 1 |
| Falkson, G | 1 |
| von Koppenfels, R | 1 |
| Müller, RP | 1 |
| Watt, J | 1 |
| Costanzi, JJ | 1 |
| Coltman, CA | 1 |
| Massey, WH | 1 |
| Dennis, DL | 1 |
| Wood, DC | 1 |
| Moskalik, KG | 1 |
| Kozlov, AP | 1 |
| Akimov, AA | 1 |
| Copeland, EM | 1 |
| Hafström, L | 2 |
| Greeff, PJ | 1 |
| Lynch, PJ | 1 |
| Sparwald, E | 1 |
| Müllensiefen, C | 1 |
| Lange, G | 1 |
| Slanina, I | 1 |
| The, KK | 1 |
| Hecker, D | 1 |
| Klug, H | 1 |
| Tanneberger, S | 1 |
| Rose, H | 1 |
| Freckman, HA | 1 |
| Larsen, RR | 1 |
| Ammon, J | 1 |
| Hermann, HJ | 1 |
| Janssen, B | 1 |
| Schmidt, L | 1 |
| Günther, W | 1 |
| Zala, L | 1 |
| Astrakhan, VI | 1 |
| Nathanson, L | 1 |
| Hall, TC | 1 |
| Schilling, A | 1 |
| Miller, S | 1 |
| Burdette, WJ | 1 |
| Gleason, MC | 1 |
| Kokame, GM | 1 |
| Horton, J | 1 |
| Olson, K | 1 |
| Mannes, P | 1 |
| Derriks, R | 1 |
| Moens, R | 1 |
| Heynen, E | 1 |
| Couture, J | 1 |
| Deschênes, L | 1 |
| Almersjö, O | 1 |
| Bengmark, S | 1 |
| Rudenstam, CM | 1 |
| Nilsson, LA | 1 |
| O'Brien, PH | 1 |
| Artz, CP | 1 |
| Belisario, JC | 1 |
| Cavins, JA | 1 |
| Jones, HW | 1 |
| Droegemueller, W | 1 |
| Makowski, EL | 1 |
| Chevrel, B | 1 |
| Chevrel, JP | 1 |
| Hanham, IW | 1 |
| Newton, KA | 1 |
| Westbury, G | 1 |
| Zeligman, I | 1 |
| Lutzner, MA | 1 |
| Scott, CI | 1 |
| Banzet, P | 1 |
| De la Caffinière, JY | 1 |
| Dufourmentel, C | 1 |
| Laugier, P | 1 |
| Hunziker, N | 1 |
| Shee, M | 1 |
| Spencer, SK | 1 |
| Kierland, RR | 1 |
| Tugarinov, OA | 1 |
| Smolianskaia, AZ | 1 |
| Klein, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Quantifying Systemic Immunosuppression to Personalize Cancer Therapy[NCT04941365] | 0 participants (Actual) | Interventional | 2022-07-07 | Withdrawn (stopped due to please refer to NCT05621837) | |||
| Quantifying Systemic Immunosuppression to Personalize Cancer Therapy[NCT05621837] | 1,000 participants (Anticipated) | Observational | 2022-03-10 | Recruiting | |||
| A Randomized, Open-Label, Phase II Study to Evaluate the Efficacy and Safety of Sintilimab Plus Capecitabine Versus Capecitabine Alone as Adjuvant Therapy for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma[NCT05201859] | Phase 2 | 150 participants (Anticipated) | Interventional | 2022-03-29 | Recruiting | ||
| A Multicenter Observational and Feasibility Study of Excision of Superficially Invasive Squamous Cell Carcinoma (SISCCA) of the Anal Canal and Perianus in HIV-Infected Persons[NCT02437851] | Phase 2 | 16 participants (Actual) | Interventional | 2015-04-30 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
19 reviews available for fluorouracil and Melanoma
| Article | Year |
|---|---|
Topical treatments for skin cancer.
Topics: Administration, Cutaneous; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; D | 2020 |
Topical treatments for skin cancer.
Topics: Administration, Cutaneous; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; D | 2020 |
Topical treatments for skin cancer.
Topics: Administration, Cutaneous; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; D | 2020 |
Nanotechnology approaches in the current therapy of skin cancer.
Topics: Administration, Cutaneous; Antineoplastic Agents; Dacarbazine; Drug Carriers; Drug Resistance, Neopl | 2020 |
Nanotechnology approaches in the current therapy of skin cancer.
Topics: Administration, Cutaneous; Antineoplastic Agents; Dacarbazine; Drug Carriers; Drug Resistance, Neopl | 2020 |
Nanotechnology approaches in the current therapy of skin cancer.
Topics: Administration, Cutaneous; Antineoplastic Agents; Dacarbazine; Drug Carriers; Drug Resistance, Neopl | 2020 |
A Network Meta-Analysis of Non-Melanoma Skin Cancer (NMSC) Treatments: Efficacy and Safety Assessment.
Topics: Aminoquinolines; Cryotherapy; Fluorouracil; Humans; Imiquimod; Melanoma; Photochemotherapy; PubMed; | 2017 |
A Network Meta-Analysis of Non-Melanoma Skin Cancer (NMSC) Treatments: Efficacy and Safety Assessment.
Topics: Aminoquinolines; Cryotherapy; Fluorouracil; Humans; Imiquimod; Melanoma; Photochemotherapy; PubMed; | 2017 |
A Network Meta-Analysis of Non-Melanoma Skin Cancer (NMSC) Treatments: Efficacy and Safety Assessment.
Topics: Aminoquinolines; Cryotherapy; Fluorouracil; Humans; Imiquimod; Melanoma; Photochemotherapy; PubMed; | 2017 |
Mediators of Inflammation in Topical Therapy of Skin Cancers.
Topics: Administration, Topical; Aminoquinolines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineop | 2019 |
Mediators of Inflammation in Topical Therapy of Skin Cancers.
Topics: Administration, Topical; Aminoquinolines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineop | 2019 |
Mediators of Inflammation in Topical Therapy of Skin Cancers.
Topics: Administration, Topical; Aminoquinolines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineop | 2019 |
Microinvasive melanoma: cutaneous pharmacotherapeutic approaches.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Ne | 2013 |
Microinvasive melanoma: cutaneous pharmacotherapeutic approaches.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Ne | 2013 |
Microinvasive melanoma: cutaneous pharmacotherapeutic approaches.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Ne | 2013 |
Intralesional agents in the management of cutaneous malignancy: a review.
Topics: Aminolevulinic Acid; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bleomycin; Carci | 2011 |
Intralesional agents in the management of cutaneous malignancy: a review.
Topics: Aminolevulinic Acid; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bleomycin; Carci | 2011 |
Intralesional agents in the management of cutaneous malignancy: a review.
Topics: Aminolevulinic Acid; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bleomycin; Carci | 2011 |
[Cutaneous neoplasms].
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bio | 2003 |
[Cutaneous neoplasms].
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bio | 2003 |
[Cutaneous neoplasms].
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Bio | 2003 |
The systemic chemotherapy of hepatic metastases.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Dacarbazine; D | 1983 |
The systemic chemotherapy of hepatic metastases.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Dacarbazine; D | 1983 |
The systemic chemotherapy of hepatic metastases.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Dacarbazine; D | 1983 |
The prevention of cutaneous malignant melanoma: high-risk groups, chemoprevention, education, and screening.
Topics: Animals; Anticarcinogenic Agents; Dysplastic Nevus Syndrome; Eflornithine; Fluorouracil; Humans; Mas | 1993 |
The prevention of cutaneous malignant melanoma: high-risk groups, chemoprevention, education, and screening.
Topics: Animals; Anticarcinogenic Agents; Dysplastic Nevus Syndrome; Eflornithine; Fluorouracil; Humans; Mas | 1993 |
The prevention of cutaneous malignant melanoma: high-risk groups, chemoprevention, education, and screening.
Topics: Animals; Anticarcinogenic Agents; Dysplastic Nevus Syndrome; Eflornithine; Fluorouracil; Humans; Mas | 1993 |
Isolated liver perfusion for liver metastases: pharmacokinetic advantage?
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; | 1996 |
Isolated liver perfusion for liver metastases: pharmacokinetic advantage?
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; | 1996 |
Isolated liver perfusion for liver metastases: pharmacokinetic advantage?
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; | 1996 |
[Cytokines and cancer: update in 1998].
Topics: Antineoplastic Agents; Fluorouracil; Humans; Interferon-gamma; Interferons; Interleukin-2; Kidney Ne | 1999 |
[Cytokines and cancer: update in 1998].
Topics: Antineoplastic Agents; Fluorouracil; Humans; Interferon-gamma; Interferons; Interleukin-2; Kidney Ne | 1999 |
[Cytokines and cancer: update in 1998].
Topics: Antineoplastic Agents; Fluorouracil; Humans; Interferon-gamma; Interferons; Interleukin-2; Kidney Ne | 1999 |
Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus | 1999 |
Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus | 1999 |
Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus | 1999 |
Multimodal primary cancer treatment (adjuvant chemotherapy): current results and future prospects.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Colonic Neoplasms; Evaluation Stud | 1979 |
Multimodal primary cancer treatment (adjuvant chemotherapy): current results and future prospects.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Colonic Neoplasms; Evaluation Stud | 1979 |
Multimodal primary cancer treatment (adjuvant chemotherapy): current results and future prospects.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Colonic Neoplasms; Evaluation Stud | 1979 |
A role for topical 5-fluorouracil therapy in melanoma.
Topics: Administration, Topical; Adult; Aged; Child; Female; Fluorouracil; Humans; Male; Melanoma; Skin Neop | 1988 |
A role for topical 5-fluorouracil therapy in melanoma.
Topics: Administration, Topical; Adult; Aged; Child; Female; Fluorouracil; Humans; Male; Melanoma; Skin Neop | 1988 |
A role for topical 5-fluorouracil therapy in melanoma.
Topics: Administration, Topical; Adult; Aged; Child; Female; Fluorouracil; Humans; Male; Melanoma; Skin Neop | 1988 |
Bromodeoxyuridine mutagenesis and deoxyribonucleotide pool imbalance in mammalian cells.
Topics: Animals; Base Composition; Bromodeoxyuridine; Cell Line; Cricetinae; Cytarabine; Deoxyadenosines; De | 1985 |
Bromodeoxyuridine mutagenesis and deoxyribonucleotide pool imbalance in mammalian cells.
Topics: Animals; Base Composition; Bromodeoxyuridine; Cell Line; Cricetinae; Cytarabine; Deoxyadenosines; De | 1985 |
Bromodeoxyuridine mutagenesis and deoxyribonucleotide pool imbalance in mammalian cells.
Topics: Animals; Base Composition; Bromodeoxyuridine; Cell Line; Cricetinae; Cytarabine; Deoxyadenosines; De | 1985 |
Neurologic complications of systemic cancer.
Topics: Arachnoid; Bacterial Infections; Brain; Brain Neoplasms; Cerebrovascular Disorders; Cisplatin; Disse | 1985 |
Neurologic complications of systemic cancer.
Topics: Arachnoid; Bacterial Infections; Brain; Brain Neoplasms; Cerebrovascular Disorders; Cisplatin; Disse | 1985 |
Neurologic complications of systemic cancer.
Topics: Arachnoid; Bacterial Infections; Brain; Brain Neoplasms; Cerebrovascular Disorders; Cisplatin; Disse | 1985 |
The use of cytotoxic drugs in the surgery of malignant disease.
Topics: Abdominal Neoplasms; Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Carcinoma, | 1968 |
The use of cytotoxic drugs in the surgery of malignant disease.
Topics: Abdominal Neoplasms; Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Carcinoma, | 1968 |
The use of cytotoxic drugs in the surgery of malignant disease.
Topics: Abdominal Neoplasms; Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Carcinoma, | 1968 |
[Use of optical quantum generators (lasers) in oncology].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bronchial Neoplasms; Carcinoma, Basal Cell; Carcinom | 1972 |
[Use of optical quantum generators (lasers) in oncology].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bronchial Neoplasms; Carcinoma, Basal Cell; Carcinom | 1972 |
[Use of optical quantum generators (lasers) in oncology].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bronchial Neoplasms; Carcinoma, Basal Cell; Carcinom | 1972 |
Current progress in the management of cancer. A collective review.
Topics: Adenocarcinoma; Angiography; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Division; Chem | 1969 |
Current progress in the management of cancer. A collective review.
Topics: Adenocarcinoma; Angiography; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Division; Chem | 1969 |
Current progress in the management of cancer. A collective review.
Topics: Adenocarcinoma; Angiography; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Division; Chem | 1969 |
11 trials available for fluorouracil and Melanoma
| Article | Year |
|---|---|
Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Mucoepidermoid; Carcinoma, Non-Small-Cell Lung; Es | 2011 |
Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Mucoepidermoid; Carcinoma, Non-Small-Cell Lung; Es | 2011 |
Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Mucoepidermoid; Carcinoma, Non-Small-Cell Lung; Es | 2011 |
Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Antineopla | 2012 |
Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Antineopla | 2012 |
Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Antineopla | 2012 |
Newer techniques in cancer chemotherapy.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bleomycin; Bone Marrow Transplantation; Carcinoma; Ce | 1984 |
Newer techniques in cancer chemotherapy.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bleomycin; Bone Marrow Transplantation; Carcinoma; Ce | 1984 |
Newer techniques in cancer chemotherapy.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bleomycin; Bone Marrow Transplantation; Carcinoma; Ce | 1984 |
The systemic chemotherapy of hepatic metastases.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Dacarbazine; D | 1983 |
The systemic chemotherapy of hepatic metastases.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Dacarbazine; D | 1983 |
The systemic chemotherapy of hepatic metastases.
Topics: Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Colonic Neoplasms; Dacarbazine; D | 1983 |
Regional perfusion with hemofiltration (chemofiltration) for the treatment of patients with regionally advanced cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma | 1996 |
Regional perfusion with hemofiltration (chemofiltration) for the treatment of patients with regionally advanced cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma | 1996 |
Regional perfusion with hemofiltration (chemofiltration) for the treatment of patients with regionally advanced cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma | 1996 |
Recombinant interferon-alpha2a plus 5-fluorouracil for the treatment of metastatic melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Interfero | 1997 |
Recombinant interferon-alpha2a plus 5-fluorouracil for the treatment of metastatic melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Interfero | 1997 |
Recombinant interferon-alpha2a plus 5-fluorouracil for the treatment of metastatic melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Interfero | 1997 |
Chemoimmunotherapy in disseminated melanoma and colorectal carcinoma.
Topics: Bacterial Vaccines; Colonic Neoplasms; Corynebacterium; Dacarbazine; Female; Fluorouracil; Humans; I | 1978 |
Chemoimmunotherapy in disseminated melanoma and colorectal carcinoma.
Topics: Bacterial Vaccines; Colonic Neoplasms; Corynebacterium; Dacarbazine; Female; Fluorouracil; Humans; I | 1978 |
Chemoimmunotherapy in disseminated melanoma and colorectal carcinoma.
Topics: Bacterial Vaccines; Colonic Neoplasms; Corynebacterium; Dacarbazine; Female; Fluorouracil; Humans; I | 1978 |
Immunology and adjuvant chemoimmunotherapy of breast cancer.
Topics: Aged; Animals; Antibodies, Neoplasm; BCG Vaccine; Breast Neoplasms; Carcinoma; Chick Embryo; Cycloph | 1976 |
Immunology and adjuvant chemoimmunotherapy of breast cancer.
Topics: Aged; Animals; Antibodies, Neoplasm; BCG Vaccine; Breast Neoplasms; Carcinoma; Chick Embryo; Cycloph | 1976 |
Immunology and adjuvant chemoimmunotherapy of breast cancer.
Topics: Aged; Animals; Antibodies, Neoplasm; BCG Vaccine; Breast Neoplasms; Carcinoma; Chick Embryo; Cycloph | 1976 |
A phase II study of cisplatinum and continuous infusion 5-fluorouracil for metastatic melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Humans | 1992 |
A phase II study of cisplatinum and continuous infusion 5-fluorouracil for metastatic melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Humans | 1992 |
A phase II study of cisplatinum and continuous infusion 5-fluorouracil for metastatic melanoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Fluorouracil; Humans | 1992 |
[Main problems of the method of clinical study of new antineoplastic agents].
Topics: Antineoplastic Agents; Biopsy; Clinical Trials as Topic; Female; Fluorouracil; Humans; Intestinal Po | 1966 |
[Main problems of the method of clinical study of new antineoplastic agents].
Topics: Antineoplastic Agents; Biopsy; Clinical Trials as Topic; Female; Fluorouracil; Humans; Intestinal Po | 1966 |
[Main problems of the method of clinical study of new antineoplastic agents].
Topics: Antineoplastic Agents; Biopsy; Clinical Trials as Topic; Female; Fluorouracil; Humans; Intestinal Po | 1966 |
Concurrent combination chemotherapy of human solid tumors: experience with a three-drug regimen and review of the literature.
Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Neoplasms; Carcinoma; Child; Child, Preschool; Clinical T | 1969 |
Concurrent combination chemotherapy of human solid tumors: experience with a three-drug regimen and review of the literature.
Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Neoplasms; Carcinoma; Child; Child, Preschool; Clinical T | 1969 |
Concurrent combination chemotherapy of human solid tumors: experience with a three-drug regimen and review of the literature.
Topics: Adolescent; Adult; Aged; Bone Marrow; Bone Neoplasms; Carcinoma; Child; Child, Preschool; Clinical T | 1969 |
173 other studies available for fluorouracil and Melanoma
| Article | Year |
|---|---|
Antitumor agents. 25. Synthesis and antitumor activity of uracil and thymine alpha-methylene-gamma-lactones and related derivatives.
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Lactones; Leukemia, Experimental; Male; Melan | 1977 |
Antitumor agents. 25. Synthesis and antitumor activity of uracil and thymine alpha-methylene-gamma-lactones and related derivatives.
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Lactones; Leukemia, Experimental; Male; Melan | 1977 |
Antitumor agents. 25. Synthesis and antitumor activity of uracil and thymine alpha-methylene-gamma-lactones and related derivatives.
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Lactones; Leukemia, Experimental; Male; Melan | 1977 |
New spirostanol steroids and steroidal saponins from roots and rhizomes of Dracaena angustifolia and their antiproliferative activity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Colonic Neoplasms; Doxorubicin; Fibrosarcoma; Humans; Li | 2001 |
New spirostanol steroids and steroidal saponins from roots and rhizomes of Dracaena angustifolia and their antiproliferative activity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Colonic Neoplasms; Doxorubicin; Fibrosarcoma; Humans; Li | 2001 |
New spirostanol steroids and steroidal saponins from roots and rhizomes of Dracaena angustifolia and their antiproliferative activity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Colonic Neoplasms; Doxorubicin; Fibrosarcoma; Humans; Li | 2001 |
Controlled release of 5-fluorouracil to melanoma cells using a hydrogel/micelle composites based on deoxycholic acid and carboxymethyl chitosan.
Topics: Chitosan; Delayed-Action Preparations; Deoxycholic Acid; Drug Carriers; Drug Delivery Systems; Fluor | 2022 |
Controlled release of 5-fluorouracil to melanoma cells using a hydrogel/micelle composites based on deoxycholic acid and carboxymethyl chitosan.
Topics: Chitosan; Delayed-Action Preparations; Deoxycholic Acid; Drug Carriers; Drug Delivery Systems; Fluor | 2022 |
Controlled release of 5-fluorouracil to melanoma cells using a hydrogel/micelle composites based on deoxycholic acid and carboxymethyl chitosan.
Topics: Chitosan; Delayed-Action Preparations; Deoxycholic Acid; Drug Carriers; Drug Delivery Systems; Fluor | 2022 |
Agent-based Modeling of Tumor and Immune System Interactions in Combinational Therapy with Low-dose 5-fluorouracil and Dendritic Cell Vaccine in Melanoma B16F10.
Topics: Animals; CD8-Positive T-Lymphocytes; Dendritic Cells; Female; Fluorouracil; Male; Melanoma; Mice; Mi | 2022 |
Agent-based Modeling of Tumor and Immune System Interactions in Combinational Therapy with Low-dose 5-fluorouracil and Dendritic Cell Vaccine in Melanoma B16F10.
Topics: Animals; CD8-Positive T-Lymphocytes; Dendritic Cells; Female; Fluorouracil; Male; Melanoma; Mice; Mi | 2022 |
Agent-based Modeling of Tumor and Immune System Interactions in Combinational Therapy with Low-dose 5-fluorouracil and Dendritic Cell Vaccine in Melanoma B16F10.
Topics: Animals; CD8-Positive T-Lymphocytes; Dendritic Cells; Female; Fluorouracil; Male; Melanoma; Mice; Mi | 2022 |
Polymer-Coated Polymeric (PCP) Microneedles for Controlled Dermal Delivery of 5-Fluorouracil.
Topics: Epidermis; Fluorouracil; Humans; Melanoma; Polymers; Povidone | 2022 |
Polymer-Coated Polymeric (PCP) Microneedles for Controlled Dermal Delivery of 5-Fluorouracil.
Topics: Epidermis; Fluorouracil; Humans; Melanoma; Polymers; Povidone | 2022 |
Polymer-Coated Polymeric (PCP) Microneedles for Controlled Dermal Delivery of 5-Fluorouracil.
Topics: Epidermis; Fluorouracil; Humans; Melanoma; Polymers; Povidone | 2022 |
Polymer-Coated Polymeric (PCP) Microneedles for Controlled Dermal Delivery of 5-Fluorouracil.
Topics: Epidermis; Fluorouracil; Humans; Melanoma; Polymers; Povidone | 2022 |
Polymer-Coated Polymeric (PCP) Microneedles for Controlled Dermal Delivery of 5-Fluorouracil.
Topics: Epidermis; Fluorouracil; Humans; Melanoma; Polymers; Povidone | 2022 |
Polymer-Coated Polymeric (PCP) Microneedles for Controlled Dermal Delivery of 5-Fluorouracil.
Topics: Epidermis; Fluorouracil; Humans; Melanoma; Polymers; Povidone | 2022 |
Polymer-Coated Polymeric (PCP) Microneedles for Controlled Dermal Delivery of 5-Fluorouracil.
Topics: Epidermis; Fluorouracil; Humans; Melanoma; Polymers; Povidone | 2022 |
Polymer-Coated Polymeric (PCP) Microneedles for Controlled Dermal Delivery of 5-Fluorouracil.
Topics: Epidermis; Fluorouracil; Humans; Melanoma; Polymers; Povidone | 2022 |
Polymer-Coated Polymeric (PCP) Microneedles for Controlled Dermal Delivery of 5-Fluorouracil.
Topics: Epidermis; Fluorouracil; Humans; Melanoma; Polymers; Povidone | 2022 |
Polymer-Coated Polymeric (PCP) Microneedles for Controlled Dermal Delivery of 5-Fluorouracil.
Topics: Epidermis; Fluorouracil; Humans; Melanoma; Polymers; Povidone | 2022 |
Polymer-Coated Polymeric (PCP) Microneedles for Controlled Dermal Delivery of 5-Fluorouracil.
Topics: Epidermis; Fluorouracil; Humans; Melanoma; Polymers; Povidone | 2022 |
Polymer-Coated Polymeric (PCP) Microneedles for Controlled Dermal Delivery of 5-Fluorouracil.
Topics: Epidermis; Fluorouracil; Humans; Melanoma; Polymers; Povidone | 2022 |
Solid lipid-based nanoparticulate system for sustained release and enhanced in-vitro cytotoxic effect of 5-fluorouracil on skin Melanoma and squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Delayed-Action Preparations; Fluorouracil; | 2023 |
Solid lipid-based nanoparticulate system for sustained release and enhanced in-vitro cytotoxic effect of 5-fluorouracil on skin Melanoma and squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Delayed-Action Preparations; Fluorouracil; | 2023 |
Solid lipid-based nanoparticulate system for sustained release and enhanced in-vitro cytotoxic effect of 5-fluorouracil on skin Melanoma and squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Delayed-Action Preparations; Fluorouracil; | 2023 |
Suicide-Gene-Modified Extracellular Vesicles of Human Primary Uveal Melanoma in Future Therapies.
Topics: Animals; Extracellular Vesicles; Flucytosine; Fluorouracil; Humans; Melanoma; Skin Neoplasms; Uveal | 2023 |
Suicide-Gene-Modified Extracellular Vesicles of Human Primary Uveal Melanoma in Future Therapies.
Topics: Animals; Extracellular Vesicles; Flucytosine; Fluorouracil; Humans; Melanoma; Skin Neoplasms; Uveal | 2023 |
Suicide-Gene-Modified Extracellular Vesicles of Human Primary Uveal Melanoma in Future Therapies.
Topics: Animals; Extracellular Vesicles; Flucytosine; Fluorouracil; Humans; Melanoma; Skin Neoplasms; Uveal | 2023 |
Photodynamic therapy enhances skin cancer chemotherapy effects through autophagy regulation.
Topics: Adenine; Aminolevulinic Acid; Autophagy; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferat | 2019 |
Photodynamic therapy enhances skin cancer chemotherapy effects through autophagy regulation.
Topics: Adenine; Aminolevulinic Acid; Autophagy; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferat | 2019 |
Photodynamic therapy enhances skin cancer chemotherapy effects through autophagy regulation.
Topics: Adenine; Aminolevulinic Acid; Autophagy; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferat | 2019 |
Appearance of cutaneous melanoma and subcutaneous metastases in metastatic gastric carcinoma undergoing chemotherapy with oral 5-fluorouracil prodrug.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2019 |
Appearance of cutaneous melanoma and subcutaneous metastases in metastatic gastric carcinoma undergoing chemotherapy with oral 5-fluorouracil prodrug.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2019 |
Appearance of cutaneous melanoma and subcutaneous metastases in metastatic gastric carcinoma undergoing chemotherapy with oral 5-fluorouracil prodrug.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2019 |
Folate-induced nanostructural changes of oligochitosan nanoparticles and their fate of cellular internalization by melanoma.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chitin; Chitosan; Drug Carriers; Fluorouracil; Folic Acid; | 2020 |
Folate-induced nanostructural changes of oligochitosan nanoparticles and their fate of cellular internalization by melanoma.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chitin; Chitosan; Drug Carriers; Fluorouracil; Folic Acid; | 2020 |
Folate-induced nanostructural changes of oligochitosan nanoparticles and their fate of cellular internalization by melanoma.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chitin; Chitosan; Drug Carriers; Fluorouracil; Folic Acid; | 2020 |
Surface modified nanoliposome formulations provide sustained release for 5-FU and increase cytotoxicity on A431 cell line.
Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Delayed-Action Preparations; Drug Liberation; Exc | 2020 |
Surface modified nanoliposome formulations provide sustained release for 5-FU and increase cytotoxicity on A431 cell line.
Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Delayed-Action Preparations; Drug Liberation; Exc | 2020 |
Surface modified nanoliposome formulations provide sustained release for 5-FU and increase cytotoxicity on A431 cell line.
Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Delayed-Action Preparations; Drug Liberation; Exc | 2020 |
Antitumor efficacy of oncolytic HSV-1 expressing cytosine deaminase is synergistically enhanced by DPD down-regulation and EMT inhibition in uveal melanoma xenograft.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modality Therapy; Cytosine De | 2020 |
Antitumor efficacy of oncolytic HSV-1 expressing cytosine deaminase is synergistically enhanced by DPD down-regulation and EMT inhibition in uveal melanoma xenograft.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modality Therapy; Cytosine De | 2020 |
Antitumor efficacy of oncolytic HSV-1 expressing cytosine deaminase is synergistically enhanced by DPD down-regulation and EMT inhibition in uveal melanoma xenograft.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Combined Modality Therapy; Cytosine De | 2020 |
Combined chemotherapy of platinum and fluorouracil promotes T cell-mediated antitumor immunity.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; CD8-Positive T- | 2021 |
Combined chemotherapy of platinum and fluorouracil promotes T cell-mediated antitumor immunity.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; CD8-Positive T- | 2021 |
Combined chemotherapy of platinum and fluorouracil promotes T cell-mediated antitumor immunity.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; CD8-Positive T- | 2021 |
N-acylsphingosine amidohydrolase 1 promotes melanoma growth and metastasis by suppressing peroxisome biogenesis-induced ROS production.
Topics: Acid Ceramidase; Animals; Carcinogenesis; Cell Line, Tumor; Ceramides; E2F1 Transcription Factor; Fl | 2021 |
N-acylsphingosine amidohydrolase 1 promotes melanoma growth and metastasis by suppressing peroxisome biogenesis-induced ROS production.
Topics: Acid Ceramidase; Animals; Carcinogenesis; Cell Line, Tumor; Ceramides; E2F1 Transcription Factor; Fl | 2021 |
N-acylsphingosine amidohydrolase 1 promotes melanoma growth and metastasis by suppressing peroxisome biogenesis-induced ROS production.
Topics: Acid Ceramidase; Animals; Carcinogenesis; Cell Line, Tumor; Ceramides; E2F1 Transcription Factor; Fl | 2021 |
Melanoma or pseudo-melanoma? Change in a pigmented lesion after application of topical 5-Fluorouracil.
Topics: Administration, Topical; Female; Fluorouracil; Humans; Melanoma; Middle Aged; Skin Neoplasms; Skin P | 2018 |
Melanoma or pseudo-melanoma? Change in a pigmented lesion after application of topical 5-Fluorouracil.
Topics: Administration, Topical; Female; Fluorouracil; Humans; Melanoma; Middle Aged; Skin Neoplasms; Skin P | 2018 |
Melanoma or pseudo-melanoma? Change in a pigmented lesion after application of topical 5-Fluorouracil.
Topics: Administration, Topical; Female; Fluorouracil; Humans; Melanoma; Middle Aged; Skin Neoplasms; Skin P | 2018 |
Nano-formulation for topical treatment of precancerous lesions: skin penetration, in vitro, and in vivo toxicological evaluation.
Topics: Administration, Cutaneous; Administration, Topical; Adult; Animals; Antineoplastic Agents; Apoptosis | 2018 |
Nano-formulation for topical treatment of precancerous lesions: skin penetration, in vitro, and in vivo toxicological evaluation.
Topics: Administration, Cutaneous; Administration, Topical; Adult; Animals; Antineoplastic Agents; Apoptosis | 2018 |
Nano-formulation for topical treatment of precancerous lesions: skin penetration, in vitro, and in vivo toxicological evaluation.
Topics: Administration, Cutaneous; Administration, Topical; Adult; Animals; Antineoplastic Agents; Apoptosis | 2018 |
5-Fluorouracil ethosomes - skin deposition and melanoma permeation synergism with microwave.
Topics: Animals; Cell Line, Tumor; Drug Carriers; Endocytosis; Fluorouracil; Male; Mechanical Phenomena; Mel | 2018 |
5-Fluorouracil ethosomes - skin deposition and melanoma permeation synergism with microwave.
Topics: Animals; Cell Line, Tumor; Drug Carriers; Endocytosis; Fluorouracil; Male; Mechanical Phenomena; Mel | 2018 |
5-Fluorouracil ethosomes - skin deposition and melanoma permeation synergism with microwave.
Topics: Animals; Cell Line, Tumor; Drug Carriers; Endocytosis; Fluorouracil; Male; Mechanical Phenomena; Mel | 2018 |
Lidocaine sensitizes the cytotoxicity of 5-fluorouacil in melanoma cells
Topics: Anesthetics, Local; Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Cell Line, Tumor; | 2017 |
Lidocaine sensitizes the cytotoxicity of 5-fluorouacil in melanoma cells
Topics: Anesthetics, Local; Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Cell Line, Tumor; | 2017 |
Lidocaine sensitizes the cytotoxicity of 5-fluorouacil in melanoma cells
Topics: Anesthetics, Local; Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Cell Line, Tumor; | 2017 |
Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice.
Topics: Animals; Cancer Vaccines; CD8-Positive T-Lymphocytes; Dendritic Cells; Female; Fluorouracil; Humans; | 2018 |
Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice.
Topics: Animals; Cancer Vaccines; CD8-Positive T-Lymphocytes; Dendritic Cells; Female; Fluorouracil; Humans; | 2018 |
Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice.
Topics: Animals; Cancer Vaccines; CD8-Positive T-Lymphocytes; Dendritic Cells; Female; Fluorouracil; Humans; | 2018 |
Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Drug Resistance, Neoplasm; Drug Sy | 2018 |
Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Drug Resistance, Neoplasm; Drug Sy | 2018 |
Targeting LMW-PTP to sensitize melanoma cancer cells toward chemo- and radiotherapy.
Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Dacarbazine; Drug Resistance, Neoplasm; Drug Sy | 2018 |
Chitosan-Carboxymethyl-5-Fluorouracil-Folate Conjugate Particles: Microwave Modulated Uptake by Skin and Melanoma Cells.
Topics: Administration, Cutaneous; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Fluorouracil; Folic Ac | 2018 |
Chitosan-Carboxymethyl-5-Fluorouracil-Folate Conjugate Particles: Microwave Modulated Uptake by Skin and Melanoma Cells.
Topics: Administration, Cutaneous; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Fluorouracil; Folic Ac | 2018 |
Chitosan-Carboxymethyl-5-Fluorouracil-Folate Conjugate Particles: Microwave Modulated Uptake by Skin and Melanoma Cells.
Topics: Administration, Cutaneous; Cell Line, Tumor; Chitosan; Drug Delivery Systems; Fluorouracil; Folic Ac | 2018 |
A Potential Therapy Using Engineered Stem Cells Prevented Malignant Melanoma in Cellular and Xenograft Mouse Models.
Topics: Animals; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Movement; Disease Models, Animal; Epi | 2019 |
A Potential Therapy Using Engineered Stem Cells Prevented Malignant Melanoma in Cellular and Xenograft Mouse Models.
Topics: Animals; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Movement; Disease Models, Animal; Epi | 2019 |
A Potential Therapy Using Engineered Stem Cells Prevented Malignant Melanoma in Cellular and Xenograft Mouse Models.
Topics: Animals; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Movement; Disease Models, Animal; Epi | 2019 |
pH Responsive 5-Fluorouracil Loaded Biocompatible Nanogels For Topical Chemotherapy of Aggressive Melanoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antimetabolites, Antineoplastic; Biocompatible Materials; | 2019 |
pH Responsive 5-Fluorouracil Loaded Biocompatible Nanogels For Topical Chemotherapy of Aggressive Melanoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antimetabolites, Antineoplastic; Biocompatible Materials; | 2019 |
pH Responsive 5-Fluorouracil Loaded Biocompatible Nanogels For Topical Chemotherapy of Aggressive Melanoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antimetabolites, Antineoplastic; Biocompatible Materials; | 2019 |
Topical chemotherapy for numerous superficial basal cell carcinomas years after isolated limb perfusion for melanoma.
Topics: Administration, Cutaneous; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents | 2019 |
Topical chemotherapy for numerous superficial basal cell carcinomas years after isolated limb perfusion for melanoma.
Topics: Administration, Cutaneous; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents | 2019 |
Topical chemotherapy for numerous superficial basal cell carcinomas years after isolated limb perfusion for melanoma.
Topics: Administration, Cutaneous; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents | 2019 |
A novel therapeutic combination approach for treating multiple vemurafenib-induced keratoacanthomas: systemic acitretin and intralesional fluorouracil.
Topics: Acitretin; Aged; Antineoplastic Agents; Drug Therapy, Combination; Fluorouracil; Humans; Indoles; In | 2013 |
A novel therapeutic combination approach for treating multiple vemurafenib-induced keratoacanthomas: systemic acitretin and intralesional fluorouracil.
Topics: Acitretin; Aged; Antineoplastic Agents; Drug Therapy, Combination; Fluorouracil; Humans; Indoles; In | 2013 |
A novel therapeutic combination approach for treating multiple vemurafenib-induced keratoacanthomas: systemic acitretin and intralesional fluorouracil.
Topics: Acitretin; Aged; Antineoplastic Agents; Drug Therapy, Combination; Fluorouracil; Humans; Indoles; In | 2013 |
Chemoprevention of skin cancer using low HLB surfactant nanoemulsion of 5-fluorouracil: a preliminary study.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Chemoprevention; Drug Delivery Systems; | 2015 |
Chemoprevention of skin cancer using low HLB surfactant nanoemulsion of 5-fluorouracil: a preliminary study.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Chemoprevention; Drug Delivery Systems; | 2015 |
Chemoprevention of skin cancer using low HLB surfactant nanoemulsion of 5-fluorouracil: a preliminary study.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Chemoprevention; Drug Delivery Systems; | 2015 |
High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Vaccines; CD4-Positive T-Ly | 2014 |
High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Vaccines; CD4-Positive T-Ly | 2014 |
High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Vaccines; CD4-Positive T-Ly | 2014 |
High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Vaccines; CD4-Positive T-Ly | 2014 |
High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Vaccines; CD4-Positive T-Ly | 2014 |
High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Vaccines; CD4-Positive T-Ly | 2014 |
High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Vaccines; CD4-Positive T-Ly | 2014 |
High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Vaccines; CD4-Positive T-Ly | 2014 |
High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Vaccines; CD4-Positive T-Ly | 2014 |
High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Vaccines; CD4-Positive T-Ly | 2014 |
High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Vaccines; CD4-Positive T-Ly | 2014 |
High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cancer Vaccines; CD4-Positive T-Ly | 2014 |
The marine fungal metabolite, dicitrinone B, induces A375 cell apoptosis through the ROS-related caspase pathway.
Topics: Antineoplastic Agents; Apoptosis; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cell Proliferation | 2014 |
The marine fungal metabolite, dicitrinone B, induces A375 cell apoptosis through the ROS-related caspase pathway.
Topics: Antineoplastic Agents; Apoptosis; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cell Proliferation | 2014 |
The marine fungal metabolite, dicitrinone B, induces A375 cell apoptosis through the ROS-related caspase pathway.
Topics: Antineoplastic Agents; Apoptosis; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cell Proliferation | 2014 |
Progression of KRAS mutant pancreatic adenocarcinoma during vemurafenib treatment in a patient with metastatic melanoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Capecitabine; Chemoradiotherapy; Deoxycytidine; Diseas | 2014 |
Progression of KRAS mutant pancreatic adenocarcinoma during vemurafenib treatment in a patient with metastatic melanoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Capecitabine; Chemoradiotherapy; Deoxycytidine; Diseas | 2014 |
Progression of KRAS mutant pancreatic adenocarcinoma during vemurafenib treatment in a patient with metastatic melanoma.
Topics: Adenocarcinoma; Adult; Antineoplastic Agents; Capecitabine; Chemoradiotherapy; Deoxycytidine; Diseas | 2014 |
Complete response of huge buccal malignant melanoma in an octogenarian patient to arterial chemotherapy.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fluorouracil; Humans; | 2015 |
Complete response of huge buccal malignant melanoma in an octogenarian patient to arterial chemotherapy.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fluorouracil; Humans; | 2015 |
Complete response of huge buccal malignant melanoma in an octogenarian patient to arterial chemotherapy.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Fluorouracil; Humans; | 2015 |
Maltese mushroom (Cynomorium coccineum L.) as source of oil with potential anticancer activity.
Topics: Agaricales; Animals; Antineoplastic Agents; Caco-2 Cells; Cell Line, Tumor; Cell Survival; Colonic N | 2015 |
Maltese mushroom (Cynomorium coccineum L.) as source of oil with potential anticancer activity.
Topics: Agaricales; Animals; Antineoplastic Agents; Caco-2 Cells; Cell Line, Tumor; Cell Survival; Colonic N | 2015 |
Maltese mushroom (Cynomorium coccineum L.) as source of oil with potential anticancer activity.
Topics: Agaricales; Animals; Antineoplastic Agents; Caco-2 Cells; Cell Line, Tumor; Cell Survival; Colonic N | 2015 |
Topical Delivery of 5-Fluorouracil from Pheroid™ Formulations and the In Vitro Efficacy Against Human Melanoma.
Topics: Administration, Cutaneous; Apoptosis; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Delivery Sys | 2015 |
Topical Delivery of 5-Fluorouracil from Pheroid™ Formulations and the In Vitro Efficacy Against Human Melanoma.
Topics: Administration, Cutaneous; Apoptosis; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Delivery Sys | 2015 |
Topical Delivery of 5-Fluorouracil from Pheroid™ Formulations and the In Vitro Efficacy Against Human Melanoma.
Topics: Administration, Cutaneous; Apoptosis; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Delivery Sys | 2015 |
Design, Development and Characterization of Topical Microemulsions of 5-Fluorouracil for the Treatment of Non Melanoma Skin Cancer and its Precursor Lesions.
Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relatio | 2015 |
Design, Development and Characterization of Topical Microemulsions of 5-Fluorouracil for the Treatment of Non Melanoma Skin Cancer and its Precursor Lesions.
Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relatio | 2015 |
Design, Development and Characterization of Topical Microemulsions of 5-Fluorouracil for the Treatment of Non Melanoma Skin Cancer and its Precursor Lesions.
Topics: Administration, Cutaneous; Animals; Antineoplastic Agents; Cell Proliferation; Dose-Response Relatio | 2015 |
Multiple Low Doses of 5-Fluorouracil Diminishes Immunosuppression by Myeloid Derived Suppressor Cells in Murine Melanoma Model.
Topics: Animals; CD8-Positive T-Lymphocytes; Clinical Protocols; Disease Models, Animal; Drug Dosage Calcula | 2015 |
Multiple Low Doses of 5-Fluorouracil Diminishes Immunosuppression by Myeloid Derived Suppressor Cells in Murine Melanoma Model.
Topics: Animals; CD8-Positive T-Lymphocytes; Clinical Protocols; Disease Models, Animal; Drug Dosage Calcula | 2015 |
Multiple Low Doses of 5-Fluorouracil Diminishes Immunosuppression by Myeloid Derived Suppressor Cells in Murine Melanoma Model.
Topics: Animals; CD8-Positive T-Lymphocytes; Clinical Protocols; Disease Models, Animal; Drug Dosage Calcula | 2015 |
[Adjuvant chemotherapy as a component of complex treatment for skin melanoma].
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuv | 2008 |
[Adjuvant chemotherapy as a component of complex treatment for skin melanoma].
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuv | 2008 |
[Adjuvant chemotherapy as a component of complex treatment for skin melanoma].
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuv | 2008 |
Recurrence of treated ciliary body melanoma following trabeculectomy.
Topics: Aged; Brachytherapy; Ciliary Body; Combined Modality Therapy; Conjunctival Neoplasms; Eye Enucleatio | 2009 |
Recurrence of treated ciliary body melanoma following trabeculectomy.
Topics: Aged; Brachytherapy; Ciliary Body; Combined Modality Therapy; Conjunctival Neoplasms; Eye Enucleatio | 2009 |
Recurrence of treated ciliary body melanoma following trabeculectomy.
Topics: Aged; Brachytherapy; Ciliary Body; Combined Modality Therapy; Conjunctival Neoplasms; Eye Enucleatio | 2009 |
Evolution of laparoscopic left lateral sectionectomy without the Pringle maneuver: through resection of benign and malignant tumors to living liver donation.
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Loss, Su | 2011 |
Evolution of laparoscopic left lateral sectionectomy without the Pringle maneuver: through resection of benign and malignant tumors to living liver donation.
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Loss, Su | 2011 |
Evolution of laparoscopic left lateral sectionectomy without the Pringle maneuver: through resection of benign and malignant tumors to living liver donation.
Topics: Adenocarcinoma; Adenoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Loss, Su | 2011 |
Tyrosine phosphatase inhibitor-3 sensitizes melanoma and colon cancer to biotherapeutics and chemotherapeutics.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; | 2010 |
Tyrosine phosphatase inhibitor-3 sensitizes melanoma and colon cancer to biotherapeutics and chemotherapeutics.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; | 2010 |
Tyrosine phosphatase inhibitor-3 sensitizes melanoma and colon cancer to biotherapeutics and chemotherapeutics.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; | 2010 |
Exudative, nonhealing scalp: a complication of systemic chemotherapy with capecitabine and bevacizumab.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherap | 2011 |
Exudative, nonhealing scalp: a complication of systemic chemotherapy with capecitabine and bevacizumab.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherap | 2011 |
Exudative, nonhealing scalp: a complication of systemic chemotherapy with capecitabine and bevacizumab.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherap | 2011 |
Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apigenin; Apoptosis; Blotting, Western; Car | 2012 |
Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apigenin; Apoptosis; Blotting, Western; Car | 2012 |
Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apigenin; Apoptosis; Blotting, Western; Car | 2012 |
Selenium nanoparticles as a carrier of 5-fluorouracil to achieve anticancer synergism.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Synergism; Fluorouracil; Humans; Melanoma; | 2012 |
Selenium nanoparticles as a carrier of 5-fluorouracil to achieve anticancer synergism.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Synergism; Fluorouracil; Humans; Melanoma; | 2012 |
Selenium nanoparticles as a carrier of 5-fluorouracil to achieve anticancer synergism.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Synergism; Fluorouracil; Humans; Melanoma; | 2012 |
Topical 5-fluorouracil elicits regressions of BRAF inhibitor-induced cutaneous squamous cell carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Antineoplastic Agents; Carcinoge | 2013 |
Topical 5-fluorouracil elicits regressions of BRAF inhibitor-induced cutaneous squamous cell carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Antineoplastic Agents; Carcinoge | 2013 |
Topical 5-fluorouracil elicits regressions of BRAF inhibitor-induced cutaneous squamous cell carcinoma.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Administration, Topical; Animals; Antineoplastic Agents; Carcinoge | 2013 |
Reversal effect of melanoma differentiation associated gene-7/interleukin-24 on multidrug resistance in human hepatocellular carcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Differentiation; Cell Line, Tumor; Doxorubicin; Drug Resistance, Mul | 2012 |
Reversal effect of melanoma differentiation associated gene-7/interleukin-24 on multidrug resistance in human hepatocellular carcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Differentiation; Cell Line, Tumor; Doxorubicin; Drug Resistance, Mul | 2012 |
Reversal effect of melanoma differentiation associated gene-7/interleukin-24 on multidrug resistance in human hepatocellular carcinoma cells.
Topics: Carcinoma, Hepatocellular; Cell Differentiation; Cell Line, Tumor; Doxorubicin; Drug Resistance, Mul | 2012 |
A novel treatment approach for extensive, eruptive, cutaneous squamous cell carcinomas in a patient receiving BRAF inhibitor therapy for metastatic melanoma.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorour | 2013 |
A novel treatment approach for extensive, eruptive, cutaneous squamous cell carcinomas in a patient receiving BRAF inhibitor therapy for metastatic melanoma.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorour | 2013 |
A novel treatment approach for extensive, eruptive, cutaneous squamous cell carcinomas in a patient receiving BRAF inhibitor therapy for metastatic melanoma.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Fluorour | 2013 |
Eruptive multiple lentigo-maligna-like lesions in a patient undergoing chemotherapy with an oral 5-fluorouracil prodrug for metastasizing colorectal carcinoma: a lesson for the pathogenesis of malignant melanoma?
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma; Colorectal Neoplasms | 2002 |
Eruptive multiple lentigo-maligna-like lesions in a patient undergoing chemotherapy with an oral 5-fluorouracil prodrug for metastasizing colorectal carcinoma: a lesson for the pathogenesis of malignant melanoma?
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma; Colorectal Neoplasms | 2002 |
Eruptive multiple lentigo-maligna-like lesions in a patient undergoing chemotherapy with an oral 5-fluorouracil prodrug for metastasizing colorectal carcinoma: a lesson for the pathogenesis of malignant melanoma?
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma; Colorectal Neoplasms | 2002 |
Evodiamine, a constituent of Evodiae Fructus, induces anti-proliferating effects in tumor cells.
Topics: Alkaloids; Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; b | 2003 |
Evodiamine, a constituent of Evodiae Fructus, induces anti-proliferating effects in tumor cells.
Topics: Alkaloids; Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; b | 2003 |
Evodiamine, a constituent of Evodiae Fructus, induces anti-proliferating effects in tumor cells.
Topics: Alkaloids; Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; b | 2003 |
METHODOLOGY OF PRELIMINARY CHEMOTHERAPEUTIC TRIALS IN PATIENTS WITH MALIGNANT SOLID TUMORS.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Colonic Neoplasms; Cyclophosp | 1963 |
METHODOLOGY OF PRELIMINARY CHEMOTHERAPEUTIC TRIALS IN PATIENTS WITH MALIGNANT SOLID TUMORS.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Colonic Neoplasms; Cyclophosp | 1963 |
METHODOLOGY OF PRELIMINARY CHEMOTHERAPEUTIC TRIALS IN PATIENTS WITH MALIGNANT SOLID TUMORS.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Colonic Neoplasms; Cyclophosp | 1963 |
VINCRISTINE (NSC-67574) THERAPY OF ADULT PATIENTS WITH SOLID TUMORS.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoid Tumor; Carcinoma, Bronchogenic; Carcinoma, Squamous | 1964 |
VINCRISTINE (NSC-67574) THERAPY OF ADULT PATIENTS WITH SOLID TUMORS.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoid Tumor; Carcinoma, Bronchogenic; Carcinoma, Squamous | 1964 |
VINCRISTINE (NSC-67574) THERAPY OF ADULT PATIENTS WITH SOLID TUMORS.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoid Tumor; Carcinoma, Bronchogenic; Carcinoma, Squamous | 1964 |
EFFECTS OF IONIZING IRRADIATION AND CHEMOTHERAPEUTIC AGENTS ON HUMAN CHROMOSOMES.
Topics: Antineoplastic Agents; Biomedical Research; Chlorambucil; Choriocarcinoma; Chromosome Aberrations; C | 1964 |
EFFECTS OF IONIZING IRRADIATION AND CHEMOTHERAPEUTIC AGENTS ON HUMAN CHROMOSOMES.
Topics: Antineoplastic Agents; Biomedical Research; Chlorambucil; Choriocarcinoma; Chromosome Aberrations; C | 1964 |
EFFECTS OF IONIZING IRRADIATION AND CHEMOTHERAPEUTIC AGENTS ON HUMAN CHROMOSOMES.
Topics: Antineoplastic Agents; Biomedical Research; Chlorambucil; Choriocarcinoma; Chromosome Aberrations; C | 1964 |
STUDIES ON HUMAN MELANOMA CELLS IN TISSUE CULTURE. II. EFFECTS OF SEVERAL CANCER CHEMOTHERAPEUTIC AGENTS ON CYTOLOGY AND GROWTH.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Chlorambucil; Dactinomycin; Fluorouracil; Melanoma; Me | 1964 |
STUDIES ON HUMAN MELANOMA CELLS IN TISSUE CULTURE. II. EFFECTS OF SEVERAL CANCER CHEMOTHERAPEUTIC AGENTS ON CYTOLOGY AND GROWTH.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Chlorambucil; Dactinomycin; Fluorouracil; Melanoma; Me | 1964 |
STUDIES ON HUMAN MELANOMA CELLS IN TISSUE CULTURE. II. EFFECTS OF SEVERAL CANCER CHEMOTHERAPEUTIC AGENTS ON CYTOLOGY AND GROWTH.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Chlorambucil; Dactinomycin; Fluorouracil; Melanoma; Me | 1964 |
INDIVIDUALIZED CHEMOTHERAPY BY IN VITRO DRUG SELECTION.
Topics: Antineoplastic Agents; Bone Neoplasms; Dactinomycin; Female; Floxuridine; Fluorouracil; Genital Neop | 1964 |
INDIVIDUALIZED CHEMOTHERAPY BY IN VITRO DRUG SELECTION.
Topics: Antineoplastic Agents; Bone Neoplasms; Dactinomycin; Female; Floxuridine; Fluorouracil; Genital Neop | 1964 |
INDIVIDUALIZED CHEMOTHERAPY BY IN VITRO DRUG SELECTION.
Topics: Antineoplastic Agents; Bone Neoplasms; Dactinomycin; Female; Floxuridine; Fluorouracil; Genital Neop | 1964 |
PROTRACTED AMBULATORY INFUSION CANCER CHEMOTHERAPY BY THE WATKINS CHRONOMETRIC INFUSOR.
Topics: Adenoma; Antineoplastic Agents; Breast Neoplasms; Carcinosarcoma; Colonic Neoplasms; Dermatitis, Exf | 1964 |
PROTRACTED AMBULATORY INFUSION CANCER CHEMOTHERAPY BY THE WATKINS CHRONOMETRIC INFUSOR.
Topics: Adenoma; Antineoplastic Agents; Breast Neoplasms; Carcinosarcoma; Colonic Neoplasms; Dermatitis, Exf | 1964 |
PROTRACTED AMBULATORY INFUSION CANCER CHEMOTHERAPY BY THE WATKINS CHRONOMETRIC INFUSOR.
Topics: Adenoma; Antineoplastic Agents; Breast Neoplasms; Carcinosarcoma; Colonic Neoplasms; Dermatitis, Exf | 1964 |
HYPERBARIC OXYGEN AND 5-FLUOROURACIL IN THE TREATMENT OF EXPERIMENTAL MELANOMA.
Topics: Animals; Fluorouracil; Hyperbaric Oxygenation; Melanoma; Melanoma, Experimental; Mice; Neoplasms; Ne | 1964 |
HYPERBARIC OXYGEN AND 5-FLUOROURACIL IN THE TREATMENT OF EXPERIMENTAL MELANOMA.
Topics: Animals; Fluorouracil; Hyperbaric Oxygenation; Melanoma; Melanoma, Experimental; Mice; Neoplasms; Ne | 1964 |
HYPERBARIC OXYGEN AND 5-FLUOROURACIL IN THE TREATMENT OF EXPERIMENTAL MELANOMA.
Topics: Animals; Fluorouracil; Hyperbaric Oxygenation; Melanoma; Melanoma, Experimental; Mice; Neoplasms; Ne | 1964 |
[FRICTION RUB SOUNDS IN THE ABDOMEN].
Topics: Abdomen; Auscultation; Blood Protein Electrophoresis; Cyclophosphamide; Fluorouracil; Friction; Geri | 1964 |
[FRICTION RUB SOUNDS IN THE ABDOMEN].
Topics: Abdomen; Auscultation; Blood Protein Electrophoresis; Cyclophosphamide; Fluorouracil; Friction; Geri | 1964 |
[FRICTION RUB SOUNDS IN THE ABDOMEN].
Topics: Abdomen; Auscultation; Blood Protein Electrophoresis; Cyclophosphamide; Fluorouracil; Friction; Geri | 1964 |
EFFECTIVENESS AND TOXICITY OF PROLONGED INFUSIONS OF 5-FLUOROURACIL IN THE TREATMENT OF CANCER.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Antineoplastic Agents; Carcinoma; Carcinoma, Sq | 1965 |
EFFECTIVENESS AND TOXICITY OF PROLONGED INFUSIONS OF 5-FLUOROURACIL IN THE TREATMENT OF CANCER.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Antineoplastic Agents; Carcinoma; Carcinoma, Sq | 1965 |
EFFECTIVENESS AND TOXICITY OF PROLONGED INFUSIONS OF 5-FLUOROURACIL IN THE TREATMENT OF CANCER.
Topics: Adenocarcinoma; Adenocarcinoma, Bronchiolo-Alveolar; Antineoplastic Agents; Carcinoma; Carcinoma, Sq | 1965 |
Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Cell Line, Tumor; Cytotoxicity, Immunologic; Dacarbazine; | 2004 |
Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Cell Line, Tumor; Cytotoxicity, Immunologic; Dacarbazine; | 2004 |
Treatment of melanoma with 5-fluorouracil or dacarbazine in vitro sensitizes cells to antigen-specific CTL lysis through perforin/granzyme- and Fas-mediated pathways.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Cell Line, Tumor; Cytotoxicity, Immunologic; Dacarbazine; | 2004 |
Atypical moles in a patient undergoing chemotherapy with oral 5-fluorouracil prodrug.
Topics: Aged; Antimetabolites, Antineoplastic; Diagnosis, Differential; Drug Eruptions; Fluorouracil; Humans | 2004 |
Atypical moles in a patient undergoing chemotherapy with oral 5-fluorouracil prodrug.
Topics: Aged; Antimetabolites, Antineoplastic; Diagnosis, Differential; Drug Eruptions; Fluorouracil; Humans | 2004 |
Atypical moles in a patient undergoing chemotherapy with oral 5-fluorouracil prodrug.
Topics: Aged; Antimetabolites, Antineoplastic; Diagnosis, Differential; Drug Eruptions; Fluorouracil; Humans | 2004 |
Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Animals; Antineoplastic Agents; Benzimidazo | 2004 |
Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Animals; Antineoplastic Agents; Benzimidazo | 2004 |
Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Animals; Antineoplastic Agents; Benzimidazo | 2004 |
[Radio-chemotherapy for non-resectable primary esophageal malignant melanoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Esophageal | 2004 |
[Radio-chemotherapy for non-resectable primary esophageal malignant melanoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Esophageal | 2004 |
[Radio-chemotherapy for non-resectable primary esophageal malignant melanoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Esophageal | 2004 |
Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Down-Regulation; Drug S | 2005 |
Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Down-Regulation; Drug S | 2005 |
Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Down-Regulation; Drug S | 2005 |
[The outcome of treatments for carcinoma of the external auditory canal].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemoth | 2005 |
[The outcome of treatments for carcinoma of the external auditory canal].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemoth | 2005 |
[The outcome of treatments for carcinoma of the external auditory canal].
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemoth | 2005 |
Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastoma.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Biological Assay; Bone Neoplasms; Brain Neoplasms; Breas | 2006 |
Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastoma.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Biological Assay; Bone Neoplasms; Brain Neoplasms; Breas | 2006 |
Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastoma.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Biological Assay; Bone Neoplasms; Brain Neoplasms; Breas | 2006 |
Clinically occult cutaneous metastases.
Topics: Aged; Aged, 80 and over; Anastrozole; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormon | 2006 |
Clinically occult cutaneous metastases.
Topics: Aged; Aged, 80 and over; Anastrozole; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormon | 2006 |
Clinically occult cutaneous metastases.
Topics: Aged; Aged, 80 and over; Anastrozole; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormon | 2006 |
Gamma-glutamylcysteine synthetase mediates the c-Myc-dependent response to antineoplastic agents in melanoma cells.
Topics: Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cisplatin; Fluorouracil; Glutamate-Cyste | 2007 |
Gamma-glutamylcysteine synthetase mediates the c-Myc-dependent response to antineoplastic agents in melanoma cells.
Topics: Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cisplatin; Fluorouracil; Glutamate-Cyste | 2007 |
Gamma-glutamylcysteine synthetase mediates the c-Myc-dependent response to antineoplastic agents in melanoma cells.
Topics: Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cisplatin; Fluorouracil; Glutamate-Cyste | 2007 |
Regression of radiation-induced macular edema after systemic bevacizumab.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetab | 2007 |
Regression of radiation-induced macular edema after systemic bevacizumab.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetab | 2007 |
Regression of radiation-induced macular edema after systemic bevacizumab.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetab | 2007 |
Genetic construction, expression, and characterization of a single chain anti-CEA antibody fused to cytosine deaminase from yeast.
Topics: Amino Acid Sequence; Antibodies, Monoclonal; Apoptosis; Blotting, Western; Carcinoembryonic Antigen; | 2008 |
Genetic construction, expression, and characterization of a single chain anti-CEA antibody fused to cytosine deaminase from yeast.
Topics: Amino Acid Sequence; Antibodies, Monoclonal; Apoptosis; Blotting, Western; Carcinoembryonic Antigen; | 2008 |
Genetic construction, expression, and characterization of a single chain anti-CEA antibody fused to cytosine deaminase from yeast.
Topics: Amino Acid Sequence; Antibodies, Monoclonal; Apoptosis; Blotting, Western; Carcinoembryonic Antigen; | 2008 |
Disseminated melanoma. Biologic behavior and treatment.
Topics: Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Dactinomycin; Fluorouracil; Humans; Hydrazine | 1967 |
Disseminated melanoma. Biologic behavior and treatment.
Topics: Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Dactinomycin; Fluorouracil; Humans; Hydrazine | 1967 |
Disseminated melanoma. Biologic behavior and treatment.
Topics: Antineoplastic Agents; Chlorambucil; Cyclophosphamide; Dactinomycin; Fluorouracil; Humans; Hydrazine | 1967 |
Intra-arterial infusion in tumors of the pelvis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality T | 1983 |
Intra-arterial infusion in tumors of the pelvis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality T | 1983 |
Intra-arterial infusion in tumors of the pelvis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality T | 1983 |
[Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cell Line; Cyclophosphamid | 1984 |
[Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cell Line; Cyclophosphamid | 1984 |
[Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carbazilquinone; Cell Line; Cyclophosphamid | 1984 |
Radiation and concurrent chemotherapy for the treatment of Lewis lung tumor and B16 melanoma tumor in C57/BL mice.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cesium Radioisotopes | 1984 |
Radiation and concurrent chemotherapy for the treatment of Lewis lung tumor and B16 melanoma tumor in C57/BL mice.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cesium Radioisotopes | 1984 |
Radiation and concurrent chemotherapy for the treatment of Lewis lung tumor and B16 melanoma tumor in C57/BL mice.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cesium Radioisotopes | 1984 |
[Increased cytotoxic effects of various anticancer drugs by alpha-interferon (HLBI) on human tumor xenografts in nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Syner | 1984 |
[Increased cytotoxic effects of various anticancer drugs by alpha-interferon (HLBI) on human tumor xenografts in nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Syner | 1984 |
[Increased cytotoxic effects of various anticancer drugs by alpha-interferon (HLBI) on human tumor xenografts in nude mice].
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Syner | 1984 |
Spontaneous metastasis of highly metastatic variants of mouse tumors and the effect of drugs on the metastasis.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Doxorubicin; Fluorouracil; Lung Neoplasms; Lymphatic Met | 1984 |
Spontaneous metastasis of highly metastatic variants of mouse tumors and the effect of drugs on the metastasis.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Doxorubicin; Fluorouracil; Lung Neoplasms; Lymphatic Met | 1984 |
Spontaneous metastasis of highly metastatic variants of mouse tumors and the effect of drugs on the metastasis.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Doxorubicin; Fluorouracil; Lung Neoplasms; Lymphatic Met | 1984 |
Separation of several 5-fluorouracil metabolites in various melanoma cell lines. Evidence for the synthesis of 5-fluorouracil-nucleotide sugars.
Topics: Animals; Aspartic Acid; Cell Line; Cells, Cultured; Chromatography; Deoxyuracil Nucleotides; Fluorod | 1984 |
Separation of several 5-fluorouracil metabolites in various melanoma cell lines. Evidence for the synthesis of 5-fluorouracil-nucleotide sugars.
Topics: Animals; Aspartic Acid; Cell Line; Cells, Cultured; Chromatography; Deoxyuracil Nucleotides; Fluorod | 1984 |
Separation of several 5-fluorouracil metabolites in various melanoma cell lines. Evidence for the synthesis of 5-fluorouracil-nucleotide sugars.
Topics: Animals; Aspartic Acid; Cell Line; Cells, Cultured; Chromatography; Deoxyuracil Nucleotides; Fluorod | 1984 |
In vitro assessment of cytotoxic agents in murine cancers: comparison between antiproliferative and antimetabolic assays.
Topics: Animals; Cell Line; Cell Survival; Cisplatin; DNA Replication; Doxorubicin; Fluorouracil; Kinetics; | 1984 |
In vitro assessment of cytotoxic agents in murine cancers: comparison between antiproliferative and antimetabolic assays.
Topics: Animals; Cell Line; Cell Survival; Cisplatin; DNA Replication; Doxorubicin; Fluorouracil; Kinetics; | 1984 |
In vitro assessment of cytotoxic agents in murine cancers: comparison between antiproliferative and antimetabolic assays.
Topics: Animals; Cell Line; Cell Survival; Cisplatin; DNA Replication; Doxorubicin; Fluorouracil; Kinetics; | 1984 |
Malignant tumors of the vagina. Classification and approach to treatment.
Topics: Adenocarcinoma; Adolescent; Adult; Carcinoma in Situ; Carcinoma, Squamous Cell; Child; Diethylstilbe | 1983 |
Malignant tumors of the vagina. Classification and approach to treatment.
Topics: Adenocarcinoma; Adolescent; Adult; Carcinoma in Situ; Carcinoma, Squamous Cell; Child; Diethylstilbe | 1983 |
Malignant tumors of the vagina. Classification and approach to treatment.
Topics: Adenocarcinoma; Adolescent; Adult; Carcinoma in Situ; Carcinoma, Squamous Cell; Child; Diethylstilbe | 1983 |
Assessment of antimetabolite cytotoxicity: a comparison of clonogenic assays and tritiated deoxyuridine incorporation.
Topics: Animals; Cell Cycle; Cell Line; Cell Survival; Clone Cells; Cytarabine; Deoxyuridine; Dose-Response | 1983 |
Assessment of antimetabolite cytotoxicity: a comparison of clonogenic assays and tritiated deoxyuridine incorporation.
Topics: Animals; Cell Cycle; Cell Line; Cell Survival; Clone Cells; Cytarabine; Deoxyuridine; Dose-Response | 1983 |
Assessment of antimetabolite cytotoxicity: a comparison of clonogenic assays and tritiated deoxyuridine incorporation.
Topics: Animals; Cell Cycle; Cell Line; Cell Survival; Clone Cells; Cytarabine; Deoxyuridine; Dose-Response | 1983 |
Metastasis after intravenous inoculation of highly metastatic variants of mouse tumors and the effects of several antitumor drugs on the tumors.
Topics: Adenocarcinoma; Age Factors; Animals; Antineoplastic Agents; Colonic Neoplasms; Doxorubicin; Fluorou | 1984 |
Metastasis after intravenous inoculation of highly metastatic variants of mouse tumors and the effects of several antitumor drugs on the tumors.
Topics: Adenocarcinoma; Age Factors; Animals; Antineoplastic Agents; Colonic Neoplasms; Doxorubicin; Fluorou | 1984 |
Metastasis after intravenous inoculation of highly metastatic variants of mouse tumors and the effects of several antitumor drugs on the tumors.
Topics: Adenocarcinoma; Age Factors; Animals; Antineoplastic Agents; Colonic Neoplasms; Doxorubicin; Fluorou | 1984 |
The interactions between indomethacin and cytotoxic drugs in mice bearing B-16 melanomas.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Cell Count; Cell Division; Doxorubicin; Female; Fluorouraci | 1980 |
The interactions between indomethacin and cytotoxic drugs in mice bearing B-16 melanomas.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Cell Count; Cell Division; Doxorubicin; Female; Fluorouraci | 1980 |
The interactions between indomethacin and cytotoxic drugs in mice bearing B-16 melanomas.
Topics: 16,16-Dimethylprostaglandin E2; Animals; Cell Count; Cell Division; Doxorubicin; Female; Fluorouraci | 1980 |
Clastogenicity and sister chromatid exchange induction by ftorafur.
Topics: Animals; Burkitt Lymphoma; Cell Line; Chromosomes; Chromosomes, Human; Cricetinae; Crossing Over, Ge | 1981 |
Clastogenicity and sister chromatid exchange induction by ftorafur.
Topics: Animals; Burkitt Lymphoma; Cell Line; Chromosomes; Chromosomes, Human; Cricetinae; Crossing Over, Ge | 1981 |
Clastogenicity and sister chromatid exchange induction by ftorafur.
Topics: Animals; Burkitt Lymphoma; Cell Line; Chromosomes; Chromosomes, Human; Cricetinae; Crossing Over, Ge | 1981 |
Prostaglandin E augments the effect of chemotherapy on B-16 melanoma in vivo.
Topics: Animals; Antineoplastic Agents; Dopamine; Doxorubicin; Drug Therapy, Combination; Female; Fluorourac | 1982 |
Prostaglandin E augments the effect of chemotherapy on B-16 melanoma in vivo.
Topics: Animals; Antineoplastic Agents; Dopamine; Doxorubicin; Drug Therapy, Combination; Female; Fluorourac | 1982 |
Prostaglandin E augments the effect of chemotherapy on B-16 melanoma in vivo.
Topics: Animals; Antineoplastic Agents; Dopamine; Doxorubicin; Drug Therapy, Combination; Female; Fluorourac | 1982 |
Drug activity and therapeutic synergism in cancer treatment.
Topics: Animals; Antineoplastic Agents; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration S | 1982 |
Drug activity and therapeutic synergism in cancer treatment.
Topics: Animals; Antineoplastic Agents; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration S | 1982 |
Drug activity and therapeutic synergism in cancer treatment.
Topics: Animals; Antineoplastic Agents; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration S | 1982 |
Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
Topics: Animals; Bone Marrow; Deoxyuridine; Drug Therapy, Combination; Fluorouracil; Infusions, Parenteral; | 1983 |
Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
Topics: Animals; Bone Marrow; Deoxyuridine; Drug Therapy, Combination; Fluorouracil; Infusions, Parenteral; | 1983 |
Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
Topics: Animals; Bone Marrow; Deoxyuridine; Drug Therapy, Combination; Fluorouracil; Infusions, Parenteral; | 1983 |
Phase I-phase II trial of N-phosphonacetyl-L-aspartic acid given by intravenous infusion and 5-fluorouracil given by bolus injection.
Topics: Adult; Aged; Antineoplastic Agents; Aspartic Acid; Colonic Neoplasms; Drug Administration Schedule; | 1982 |
Phase I-phase II trial of N-phosphonacetyl-L-aspartic acid given by intravenous infusion and 5-fluorouracil given by bolus injection.
Topics: Adult; Aged; Antineoplastic Agents; Aspartic Acid; Colonic Neoplasms; Drug Administration Schedule; | 1982 |
Phase I-phase II trial of N-phosphonacetyl-L-aspartic acid given by intravenous infusion and 5-fluorouracil given by bolus injection.
Topics: Adult; Aged; Antineoplastic Agents; Aspartic Acid; Colonic Neoplasms; Drug Administration Schedule; | 1982 |
Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Topics: Animals; Anthracenes; Antineoplastic Agents; Doxorubicin; Drug Administration Schedule; Drug Evaluat | 1982 |
Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Topics: Animals; Anthracenes; Antineoplastic Agents; Doxorubicin; Drug Administration Schedule; Drug Evaluat | 1982 |
Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Topics: Animals; Anthracenes; Antineoplastic Agents; Doxorubicin; Drug Administration Schedule; Drug Evaluat | 1982 |
Randomized versus historical controls for clinical trials.
Topics: Abortion, Habitual; Anticoagulants; BCG Vaccine; Clinical Trials as Topic; Colonic Neoplasms; Corona | 1982 |
Randomized versus historical controls for clinical trials.
Topics: Abortion, Habitual; Anticoagulants; BCG Vaccine; Clinical Trials as Topic; Colonic Neoplasms; Corona | 1982 |
Randomized versus historical controls for clinical trials.
Topics: Abortion, Habitual; Anticoagulants; BCG Vaccine; Clinical Trials as Topic; Colonic Neoplasms; Corona | 1982 |
Excretion of tumor-associated antigen(s) in the urine of patients with colon carcinoma.
Topics: Adult; Aged; Antigens, Neoplasm; Colonic Neoplasms; Complement Fixation Tests; Female; Fluorouracil; | 1982 |
Excretion of tumor-associated antigen(s) in the urine of patients with colon carcinoma.
Topics: Adult; Aged; Antigens, Neoplasm; Colonic Neoplasms; Complement Fixation Tests; Female; Fluorouracil; | 1982 |
Excretion of tumor-associated antigen(s) in the urine of patients with colon carcinoma.
Topics: Adult; Aged; Antigens, Neoplasm; Colonic Neoplasms; Complement Fixation Tests; Female; Fluorouracil; | 1982 |
[Antitumor effect of UFT against malignant tumors of maxillary sinus--clinical and biochemical study].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Drug Therapy, Combination; Female; Fluorourac | 1982 |
[Antitumor effect of UFT against malignant tumors of maxillary sinus--clinical and biochemical study].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Drug Therapy, Combination; Female; Fluorourac | 1982 |
[Antitumor effect of UFT against malignant tumors of maxillary sinus--clinical and biochemical study].
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Drug Therapy, Combination; Female; Fluorourac | 1982 |
[Antineoplastic activity of lambdamycin in different murine test models compared with cyclophosphamide, 6-mercaptopurine and 5-fluorouracil (author's transl)].
Topics: Animals; Benzopyrans; Carcinoma; Cyclophosphamide; Fluorouracil; Glycosides; Leukemia, Experimental; | 1981 |
[Antineoplastic activity of lambdamycin in different murine test models compared with cyclophosphamide, 6-mercaptopurine and 5-fluorouracil (author's transl)].
Topics: Animals; Benzopyrans; Carcinoma; Cyclophosphamide; Fluorouracil; Glycosides; Leukemia, Experimental; | 1981 |
[Antineoplastic activity of lambdamycin in different murine test models compared with cyclophosphamide, 6-mercaptopurine and 5-fluorouracil (author's transl)].
Topics: Animals; Benzopyrans; Carcinoma; Cyclophosphamide; Fluorouracil; Glycosides; Leukemia, Experimental; | 1981 |
[Malignant melanoma of the vagina].
Topics: Adult; BCG Vaccine; Cyclophosphamide; Drug Therapy, Combination; Eyelid Neoplasms; Female; Fluoroura | 1980 |
[Malignant melanoma of the vagina].
Topics: Adult; BCG Vaccine; Cyclophosphamide; Drug Therapy, Combination; Eyelid Neoplasms; Female; Fluoroura | 1980 |
[Malignant melanoma of the vagina].
Topics: Adult; BCG Vaccine; Cyclophosphamide; Drug Therapy, Combination; Eyelid Neoplasms; Female; Fluoroura | 1980 |
Chemotherapy against human melanoma in the hamster cheek pouch.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Carmustine; Cheek; Cricetinae; Cyclophosphamide; Da | 1980 |
Chemotherapy against human melanoma in the hamster cheek pouch.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Carmustine; Cheek; Cricetinae; Cyclophosphamide; Da | 1980 |
Chemotherapy against human melanoma in the hamster cheek pouch.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Carmustine; Cheek; Cricetinae; Cyclophosphamide; Da | 1980 |
Topical chemotherapy of dysplastic melanocytic nevi with 5% fluorouracil.
Topics: Administration, Topical; Adult; Female; Fluorouracil; Humans; Melanoma; Nevus, Pigmented | 1981 |
Topical chemotherapy of dysplastic melanocytic nevi with 5% fluorouracil.
Topics: Administration, Topical; Adult; Female; Fluorouracil; Humans; Melanoma; Nevus, Pigmented | 1981 |
Topical chemotherapy of dysplastic melanocytic nevi with 5% fluorouracil.
Topics: Administration, Topical; Adult; Female; Fluorouracil; Humans; Melanoma; Nevus, Pigmented | 1981 |
Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.
Topics: Antineoplastic Agents; Bleomycin; Carboplatin; Carmustine; Cisplatin; Dacarbazine; Dose-Response Rel | 1994 |
Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.
Topics: Antineoplastic Agents; Bleomycin; Carboplatin; Carmustine; Cisplatin; Dacarbazine; Dose-Response Rel | 1994 |
Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.
Topics: Antineoplastic Agents; Bleomycin; Carboplatin; Carmustine; Cisplatin; Dacarbazine; Dose-Response Rel | 1994 |
Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcino | 1993 |
Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcino | 1993 |
Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcino | 1993 |
Synchronization of cells in the S phase of the cell cycle by 3'-azido-3'-deoxythymidine: implications for cell cytotoxicity.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Division; Cell Survival; Colonic Neoplasms; | 1995 |
Synchronization of cells in the S phase of the cell cycle by 3'-azido-3'-deoxythymidine: implications for cell cytotoxicity.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Division; Cell Survival; Colonic Neoplasms; | 1995 |
Synchronization of cells in the S phase of the cell cycle by 3'-azido-3'-deoxythymidine: implications for cell cytotoxicity.
Topics: Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cell Division; Cell Survival; Colonic Neoplasms; | 1995 |
Response of recurrent brain metastases in malignant melanoma to 5-fluorouracil and interferon-alpha therapy.
Topics: Adult; Brain Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Interferon-alpha; M | 1994 |
Response of recurrent brain metastases in malignant melanoma to 5-fluorouracil and interferon-alpha therapy.
Topics: Adult; Brain Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Interferon-alpha; M | 1994 |
Response of recurrent brain metastases in malignant melanoma to 5-fluorouracil and interferon-alpha therapy.
Topics: Adult; Brain Neoplasms; Combined Modality Therapy; Female; Fluorouracil; Humans; Interferon-alpha; M | 1994 |
The effect of tirapazamine (SR-4233) alone or combined with chemotherapeutic agents on xenografted human tumours.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleo | 1996 |
The effect of tirapazamine (SR-4233) alone or combined with chemotherapeutic agents on xenografted human tumours.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleo | 1996 |
The effect of tirapazamine (SR-4233) alone or combined with chemotherapeutic agents on xenografted human tumours.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleo | 1996 |
The use of cationic liposomes DC-CHOL/DOPE and DDAB/DOPE for direct transfer of Escherichia coli cytosine deaminase gene into growing melanoma tumors.
Topics: Animals; Antimetabolites, Antineoplastic; Cations; Cholesterol; Cytosine Deaminase; Drug Carriers; E | 1996 |
The use of cationic liposomes DC-CHOL/DOPE and DDAB/DOPE for direct transfer of Escherichia coli cytosine deaminase gene into growing melanoma tumors.
Topics: Animals; Antimetabolites, Antineoplastic; Cations; Cholesterol; Cytosine Deaminase; Drug Carriers; E | 1996 |
The use of cationic liposomes DC-CHOL/DOPE and DDAB/DOPE for direct transfer of Escherichia coli cytosine deaminase gene into growing melanoma tumors.
Topics: Animals; Antimetabolites, Antineoplastic; Cations; Cholesterol; Cytosine Deaminase; Drug Carriers; E | 1996 |
The use of millimeter band electromagnetic waves in clinical oncology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Breast Neoplasms; Cyclophosphamide | 2000 |
The use of millimeter band electromagnetic waves in clinical oncology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Breast Neoplasms; Cyclophosphamide | 2000 |
The use of millimeter band electromagnetic waves in clinical oncology.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Breast Neoplasms; Cyclophosphamide | 2000 |
Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apopto | 2002 |
Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apopto | 2002 |
Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apopto | 2002 |
Multiple neoplasms: a case report.
Topics: Aged; Antimetabolites, Antineoplastic; Blepharoplasty; Carcinoma in Situ; Carcinoma, Squamous Cell; | 2002 |
Multiple neoplasms: a case report.
Topics: Aged; Antimetabolites, Antineoplastic; Blepharoplasty; Carcinoma in Situ; Carcinoma, Squamous Cell; | 2002 |
Multiple neoplasms: a case report.
Topics: Aged; Antimetabolites, Antineoplastic; Blepharoplasty; Carcinoma in Situ; Carcinoma, Squamous Cell; | 2002 |
Effects of antineoplastic agents on wound healing in mice.
Topics: Animals; Antineoplastic Agents; Bleomycin; Carmustine; Cyclophosphamide; Dactinomycin; Doxorubicin; | 1975 |
Effects of antineoplastic agents on wound healing in mice.
Topics: Animals; Antineoplastic Agents; Bleomycin; Carmustine; Cyclophosphamide; Dactinomycin; Doxorubicin; | 1975 |
Effects of antineoplastic agents on wound healing in mice.
Topics: Animals; Antineoplastic Agents; Bleomycin; Carmustine; Cyclophosphamide; Dactinomycin; Doxorubicin; | 1975 |
[Histological and histochemical studies on melanoma metastases under immunobiological and cytostatic therapy].
Topics: Antineoplastic Agents; BCG Vaccine; Bleomycin; Cytarabine; Dinitrochlorobenzene; Fluorouracil; Human | 1976 |
[Histological and histochemical studies on melanoma metastases under immunobiological and cytostatic therapy].
Topics: Antineoplastic Agents; BCG Vaccine; Bleomycin; Cytarabine; Dinitrochlorobenzene; Fluorouracil; Human | 1976 |
[Histological and histochemical studies on melanoma metastases under immunobiological and cytostatic therapy].
Topics: Antineoplastic Agents; BCG Vaccine; Bleomycin; Cytarabine; Dinitrochlorobenzene; Fluorouracil; Human | 1976 |
Combination chemotherapy against B16 melanoma: bleomycin/vinblastine, bleomycin/cis-diamminedichloroplatinum, 5-fluorouracil/BCNU and 5-fluorouracil/methyl-CCNU.
Topics: Animals; Antineoplastic Agents; Bleomycin; Carmustine; Cisplatin; Dose-Response Relationship, Drug; | 1978 |
Combination chemotherapy against B16 melanoma: bleomycin/vinblastine, bleomycin/cis-diamminedichloroplatinum, 5-fluorouracil/BCNU and 5-fluorouracil/methyl-CCNU.
Topics: Animals; Antineoplastic Agents; Bleomycin; Carmustine; Cisplatin; Dose-Response Relationship, Drug; | 1978 |
Combination chemotherapy against B16 melanoma: bleomycin/vinblastine, bleomycin/cis-diamminedichloroplatinum, 5-fluorouracil/BCNU and 5-fluorouracil/methyl-CCNU.
Topics: Animals; Antineoplastic Agents; Bleomycin; Carmustine; Cisplatin; Dose-Response Relationship, Drug; | 1978 |
Intraperitoneal contrast infusion for assessment of intraperitoneal fluid dynamics.
Topics: Adult; Antineoplastic Agents; Ascitic Fluid; Contrast Media; Female; Fluorouracil; Humans; Injection | 1979 |
Intraperitoneal contrast infusion for assessment of intraperitoneal fluid dynamics.
Topics: Adult; Antineoplastic Agents; Ascitic Fluid; Contrast Media; Female; Fluorouracil; Humans; Injection | 1979 |
Intraperitoneal contrast infusion for assessment of intraperitoneal fluid dynamics.
Topics: Adult; Antineoplastic Agents; Ascitic Fluid; Contrast Media; Female; Fluorouracil; Humans; Injection | 1979 |
Sensitivity tests of tumors to cytostatic agents. I. Comparative investigations on transplanted tumors in vivo and in vitro.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cell Division; Cricetinae; Da | 1975 |
Sensitivity tests of tumors to cytostatic agents. I. Comparative investigations on transplanted tumors in vivo and in vitro.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cell Division; Cricetinae; Da | 1975 |
Sensitivity tests of tumors to cytostatic agents. I. Comparative investigations on transplanted tumors in vivo and in vitro.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cell Division; Cricetinae; Da | 1975 |
Recent trends in chemotherapy of solid tumors.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Agents; Brain Neoplasms; Breast Neopl | 1975 |
Recent trends in chemotherapy of solid tumors.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Agents; Brain Neoplasms; Breast Neopl | 1975 |
Recent trends in chemotherapy of solid tumors.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Agents; Brain Neoplasms; Breast Neopl | 1975 |
Current status of regional arterial infusion chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Hepatocellular; Carotid Arteries; Catheterization; | 1975 |
Current status of regional arterial infusion chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Hepatocellular; Carotid Arteries; Catheterization; | 1975 |
Current status of regional arterial infusion chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Hepatocellular; Carotid Arteries; Catheterization; | 1975 |
Chemotherapy of common solid tumours in a general surgical unit.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Interactions; Drug Syne | 1979 |
Chemotherapy of common solid tumours in a general surgical unit.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Interactions; Drug Syne | 1979 |
Chemotherapy of common solid tumours in a general surgical unit.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Drug Interactions; Drug Syne | 1979 |
Inhibition of DNA synthesis in Harding-Passey melanoma cells by prostaglandins A1 and A2: comparison with chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; DNA Replication; DNA, Neoplasm; Doxo | 1979 |
Inhibition of DNA synthesis in Harding-Passey melanoma cells by prostaglandins A1 and A2: comparison with chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; DNA Replication; DNA, Neoplasm; Doxo | 1979 |
Inhibition of DNA synthesis in Harding-Passey melanoma cells by prostaglandins A1 and A2: comparison with chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; DNA Replication; DNA, Neoplasm; Doxo | 1979 |
The screening test of various chemotherapeutic drugs in primary malignant melanoma cells and human malignant melanoma cell line (TM-1).
Topics: Aged; Antineoplastic Agents; Cell Line; Cells, Cultured; Dactinomycin; Drug Evaluation, Preclinical; | 1979 |
The screening test of various chemotherapeutic drugs in primary malignant melanoma cells and human malignant melanoma cell line (TM-1).
Topics: Aged; Antineoplastic Agents; Cell Line; Cells, Cultured; Dactinomycin; Drug Evaluation, Preclinical; | 1979 |
The screening test of various chemotherapeutic drugs in primary malignant melanoma cells and human malignant melanoma cell line (TM-1).
Topics: Aged; Antineoplastic Agents; Cell Line; Cells, Cultured; Dactinomycin; Drug Evaluation, Preclinical; | 1979 |
Treatment of metastatic melanoma with combined 5-fluorouracil and procarbazine.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Melanoma; Middle Aged; N | 1977 |
Treatment of metastatic melanoma with combined 5-fluorouracil and procarbazine.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Melanoma; Middle Aged; N | 1977 |
Treatment of metastatic melanoma with combined 5-fluorouracil and procarbazine.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Fluorouracil; Humans; Male; Melanoma; Middle Aged; N | 1977 |
Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
Topics: Animals; Carcinoma; Cell Line; Drug Resistance; Drug Therapy, Combination; Female; Fluorouracil; Leu | 1976 |
Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
Topics: Animals; Carcinoma; Cell Line; Drug Resistance; Drug Therapy, Combination; Female; Fluorouracil; Leu | 1976 |
Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
Topics: Animals; Carcinoma; Cell Line; Drug Resistance; Drug Therapy, Combination; Female; Fluorouracil; Leu | 1976 |
Fresh explant culture of human tumours in vitro and the assessment of sensitivity to cytotoxic chemotherapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Chlorambucil; Culture Techniques; Drug Evaluation, Preclini | 1975 |
Fresh explant culture of human tumours in vitro and the assessment of sensitivity to cytotoxic chemotherapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Chlorambucil; Culture Techniques; Drug Evaluation, Preclini | 1975 |
Fresh explant culture of human tumours in vitro and the assessment of sensitivity to cytotoxic chemotherapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Chlorambucil; Culture Techniques; Drug Evaluation, Preclini | 1975 |
Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.?
Topics: Adult; Altretamine; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carmustine; Colonic Neo | 1976 |
Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.?
Topics: Adult; Altretamine; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carmustine; Colonic Neo | 1976 |
Multimodal surgical adjuvant therapy for a broad spectrum of tumors in humans.?
Topics: Adult; Altretamine; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carmustine; Colonic Neo | 1976 |
Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cyclophosphamide; Dose-Response Relationship, Drug; D | 1977 |
Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cyclophosphamide; Dose-Response Relationship, Drug; D | 1977 |
Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cyclophosphamide; Dose-Response Relationship, Drug; D | 1977 |
[Experiences in the treatment of 2 patients with xeroderma pigmentosum].
Topics: Adolescent; Adult; Brain Neoplasms; Female; Fluorouracil; Humans; Leiomyosarcoma; Male; Melanoma; Ne | 1976 |
[Experiences in the treatment of 2 patients with xeroderma pigmentosum].
Topics: Adolescent; Adult; Brain Neoplasms; Female; Fluorouracil; Humans; Leiomyosarcoma; Male; Melanoma; Ne | 1976 |
[Experiences in the treatment of 2 patients with xeroderma pigmentosum].
Topics: Adolescent; Adult; Brain Neoplasms; Female; Fluorouracil; Humans; Leiomyosarcoma; Male; Melanoma; Ne | 1976 |
Kinetic aids to proper chemotherapeutic scheduling: labeled nucleoside incorporation studies in vivo.
Topics: Animals; Bone Marrow; Cell Survival; Cyclophosphamide; DNA, Neoplasm; Drug Administration Schedule; | 1976 |
Kinetic aids to proper chemotherapeutic scheduling: labeled nucleoside incorporation studies in vivo.
Topics: Animals; Bone Marrow; Cell Survival; Cyclophosphamide; DNA, Neoplasm; Drug Administration Schedule; | 1976 |
Kinetic aids to proper chemotherapeutic scheduling: labeled nucleoside incorporation studies in vivo.
Topics: Animals; Bone Marrow; Cell Survival; Cyclophosphamide; DNA, Neoplasm; Drug Administration Schedule; | 1976 |
Immunotherapy of human solid tumors with Bacillus Calmette-Guérin: prolongation of disease-free interval and survival in malignant melanoma, breast, and colorectal cancer.
Topics: BCG Vaccine; Breast Neoplasms; Colonic Neoplasms; Dacarbazine; Doxorubicin; Female; Fluorouracil; Hu | 1976 |
Immunotherapy of human solid tumors with Bacillus Calmette-Guérin: prolongation of disease-free interval and survival in malignant melanoma, breast, and colorectal cancer.
Topics: BCG Vaccine; Breast Neoplasms; Colonic Neoplasms; Dacarbazine; Doxorubicin; Female; Fluorouracil; Hu | 1976 |
Immunotherapy of human solid tumors with Bacillus Calmette-Guérin: prolongation of disease-free interval and survival in malignant melanoma, breast, and colorectal cancer.
Topics: BCG Vaccine; Breast Neoplasms; Colonic Neoplasms; Dacarbazine; Doxorubicin; Female; Fluorouracil; Hu | 1976 |
Systemic chemotherapy of advanced head and neck malignancies.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclophosphamide; Cytarabine; Doxor | 1975 |
Systemic chemotherapy of advanced head and neck malignancies.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclophosphamide; Cytarabine; Doxor | 1975 |
Systemic chemotherapy of advanced head and neck malignancies.
Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclophosphamide; Cytarabine; Doxor | 1975 |
Chemotherapy of a human malignant melanoma transplanted in the nude mouse.
Topics: Animals; Body Weight; Dacarbazine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; F | 1975 |
Chemotherapy of a human malignant melanoma transplanted in the nude mouse.
Topics: Animals; Body Weight; Dacarbazine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; F | 1975 |
Chemotherapy of a human malignant melanoma transplanted in the nude mouse.
Topics: Animals; Body Weight; Dacarbazine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; F | 1975 |
The influence of site of metastasis on tumour growth and response to chemotherapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Chlorambucil; Female; Fluorouracil; Genital Neoplasms, Fema | 1975 |
The influence of site of metastasis on tumour growth and response to chemotherapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Chlorambucil; Female; Fluorouracil; Genital Neoplasms, Fema | 1975 |
The influence of site of metastasis on tumour growth and response to chemotherapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Chlorambucil; Female; Fluorouracil; Genital Neoplasms, Fema | 1975 |
Current thoughts on the surgical treatment of rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; | 1976 |
Current thoughts on the surgical treatment of rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; | 1976 |
Current thoughts on the surgical treatment of rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; | 1976 |
Levamisole potentiation of fluorouracil antiproliferative activity mimicked by orthovanadate, an inhibitor of tyrosine phosphatase.
Topics: Breast Neoplasms; Colonic Neoplasms; Drug Synergism; Ethers, Cyclic; Fluorouracil; Humans; Levamisol | 1992 |
Levamisole potentiation of fluorouracil antiproliferative activity mimicked by orthovanadate, an inhibitor of tyrosine phosphatase.
Topics: Breast Neoplasms; Colonic Neoplasms; Drug Synergism; Ethers, Cyclic; Fluorouracil; Humans; Levamisol | 1992 |
Levamisole potentiation of fluorouracil antiproliferative activity mimicked by orthovanadate, an inhibitor of tyrosine phosphatase.
Topics: Breast Neoplasms; Colonic Neoplasms; Drug Synergism; Ethers, Cyclic; Fluorouracil; Humans; Levamisol | 1992 |
Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell lines.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasm | 1992 |
Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell lines.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasm | 1992 |
Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell lines.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasm | 1992 |
Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazin | 1992 |
Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazin | 1992 |
Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazin | 1992 |
Abrogation of interferon-induced resistance to interferon-activated major histocompatibility complex-unrestricted killers by treatment of a melanoma cell line with 5-fluorouracil.
Topics: Adult; Cell Line; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Drug Resistance; Fluo | 1991 |
Abrogation of interferon-induced resistance to interferon-activated major histocompatibility complex-unrestricted killers by treatment of a melanoma cell line with 5-fluorouracil.
Topics: Adult; Cell Line; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Drug Resistance; Fluo | 1991 |
Abrogation of interferon-induced resistance to interferon-activated major histocompatibility complex-unrestricted killers by treatment of a melanoma cell line with 5-fluorouracil.
Topics: Adult; Cell Line; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Drug Resistance; Fluo | 1991 |
Toxicities of trichosanthin and alpha-momorcharin, abortifacient proteins from Chinese medicinal plants, on cultured tumor cell lines.
Topics: Abortifacient Agents, Nonsteroidal; Animals; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Ce | 1990 |
Toxicities of trichosanthin and alpha-momorcharin, abortifacient proteins from Chinese medicinal plants, on cultured tumor cell lines.
Topics: Abortifacient Agents, Nonsteroidal; Animals; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Ce | 1990 |
Toxicities of trichosanthin and alpha-momorcharin, abortifacient proteins from Chinese medicinal plants, on cultured tumor cell lines.
Topics: Abortifacient Agents, Nonsteroidal; Animals; Carcinoma, Hepatocellular; Carcinoma, Squamous Cell; Ce | 1990 |
Rapid chemosensitivity assay with human normal and tumor cells in vitro.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Survival; Cells, Cultured; Cisplatin; Dose-Re | 1990 |
Rapid chemosensitivity assay with human normal and tumor cells in vitro.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Survival; Cells, Cultured; Cisplatin; Dose-Re | 1990 |
Rapid chemosensitivity assay with human normal and tumor cells in vitro.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Survival; Cells, Cultured; Cisplatin; Dose-Re | 1990 |
[Study of procreation capacity of men after treatment of their malignant tumors (melanoblastoma, thyroid carcinoma) with ionizing radiation and cytostatic agents].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cobalt Radioisotopes; Cyclophospha | 1990 |
[Study of procreation capacity of men after treatment of their malignant tumors (melanoblastoma, thyroid carcinoma) with ionizing radiation and cytostatic agents].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cobalt Radioisotopes; Cyclophospha | 1990 |
[Study of procreation capacity of men after treatment of their malignant tumors (melanoblastoma, thyroid carcinoma) with ionizing radiation and cytostatic agents].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cobalt Radioisotopes; Cyclophospha | 1990 |
Differential effects of 5-fluorouracil on human skin melanocytes and malignant melanoma cells in vitro.
Topics: Cell Division; Cell Line; Cells, Cultured; DNA; DNA, Neoplasm; Fluorouracil; Humans; Melanocytes; Me | 1986 |
Differential effects of 5-fluorouracil on human skin melanocytes and malignant melanoma cells in vitro.
Topics: Cell Division; Cell Line; Cells, Cultured; DNA; DNA, Neoplasm; Fluorouracil; Humans; Melanocytes; Me | 1986 |
Differential effects of 5-fluorouracil on human skin melanocytes and malignant melanoma cells in vitro.
Topics: Cell Division; Cell Line; Cells, Cultured; DNA; DNA, Neoplasm; Fluorouracil; Humans; Melanocytes; Me | 1986 |
Conventional fractionation radiotherapy combined with 5-fluorouracil for metastatic malignant melanoma.
Topics: Abdominal Neoplasms; Adult; Aged; Cobalt Radioisotopes; Female; Fluorouracil; Humans; Liver Neoplasm | 1987 |
Conventional fractionation radiotherapy combined with 5-fluorouracil for metastatic malignant melanoma.
Topics: Abdominal Neoplasms; Adult; Aged; Cobalt Radioisotopes; Female; Fluorouracil; Humans; Liver Neoplasm | 1987 |
Conventional fractionation radiotherapy combined with 5-fluorouracil for metastatic malignant melanoma.
Topics: Abdominal Neoplasms; Adult; Aged; Cobalt Radioisotopes; Female; Fluorouracil; Humans; Liver Neoplasm | 1987 |
Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro.
Topics: Antineoplastic Agents; Bleomycin; Breast Neoplasms; Cell Survival; Cells, Cultured; Cisplatin; Doxor | 1985 |
Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro.
Topics: Antineoplastic Agents; Bleomycin; Breast Neoplasms; Cell Survival; Cells, Cultured; Cisplatin; Doxor | 1985 |
Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro.
Topics: Antineoplastic Agents; Bleomycin; Breast Neoplasms; Cell Survival; Cells, Cultured; Cisplatin; Doxor | 1985 |
[Various doses cisplatin combined with multi-drug chemotherapy of malignant solid tumors].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neop | 1989 |
[Various doses cisplatin combined with multi-drug chemotherapy of malignant solid tumors].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neop | 1989 |
[Various doses cisplatin combined with multi-drug chemotherapy of malignant solid tumors].
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neop | 1989 |
Heterogeneity of the response to inducers of differentiation and to cytostatics of tumor cell populations.
Topics: Antineoplastic Agents; Cell Differentiation; Cisplatin; Cytarabine; Dacarbazine; Dimethyl Sulfoxide; | 1988 |
Heterogeneity of the response to inducers of differentiation and to cytostatics of tumor cell populations.
Topics: Antineoplastic Agents; Cell Differentiation; Cisplatin; Cytarabine; Dacarbazine; Dimethyl Sulfoxide; | 1988 |
Heterogeneity of the response to inducers of differentiation and to cytostatics of tumor cell populations.
Topics: Antineoplastic Agents; Cell Differentiation; Cisplatin; Cytarabine; Dacarbazine; Dimethyl Sulfoxide; | 1988 |
Antitumor activity of imidazolium-bisimidazole-tetrachlororuthenate (III). A representative of a new class of inorganic antitumor agents.
Topics: Animals; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Drug Evaluation, Preclinical; Female; F | 1986 |
Antitumor activity of imidazolium-bisimidazole-tetrachlororuthenate (III). A representative of a new class of inorganic antitumor agents.
Topics: Animals; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Drug Evaluation, Preclinical; Female; F | 1986 |
Antitumor activity of imidazolium-bisimidazole-tetrachlororuthenate (III). A representative of a new class of inorganic antitumor agents.
Topics: Animals; Antineoplastic Agents; Cisplatin; Cyclophosphamide; Drug Evaluation, Preclinical; Female; F | 1986 |
Vitiligo.
Topics: Adolescent; Adult; Autoimmune Diseases; Child; Child, Preschool; Diagnosis, Differential; Female; Fl | 1986 |
Vitiligo.
Topics: Adolescent; Adult; Autoimmune Diseases; Child; Child, Preschool; Diagnosis, Differential; Female; Fl | 1986 |
Vitiligo.
Topics: Adolescent; Adult; Autoimmune Diseases; Child; Child, Preschool; Diagnosis, Differential; Female; Fl | 1986 |
Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay.
Topics: Adenocarcinoma; Altretamine; Anti-Mullerian Hormone; Ascitic Fluid; Carcinoma; Chromatography, Affin | 1985 |
Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay.
Topics: Adenocarcinoma; Altretamine; Anti-Mullerian Hormone; Ascitic Fluid; Carcinoma; Chromatography, Affin | 1985 |
Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay.
Topics: Adenocarcinoma; Altretamine; Anti-Mullerian Hormone; Ascitic Fluid; Carcinoma; Chromatography, Affin | 1985 |
[Neoplasms of the vulva].
Topics: Aged; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Erythroplasi | 1985 |
[Neoplasms of the vulva].
Topics: Aged; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Erythroplasi | 1985 |
[Neoplasms of the vulva].
Topics: Aged; Carcinoma; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cobalt Radioisotopes; Erythroplasi | 1985 |
[Mitomycin alone and in therapeutic association in the palliative treatment of solid tumors].
Topics: Antineoplastic Agents; Breast Neoplasms; Cobalt Isotopes; Cyclophosphamide; Drug Combinations; Femal | 1971 |
[Mitomycin alone and in therapeutic association in the palliative treatment of solid tumors].
Topics: Antineoplastic Agents; Breast Neoplasms; Cobalt Isotopes; Cyclophosphamide; Drug Combinations; Femal | 1971 |
[Mitomycin alone and in therapeutic association in the palliative treatment of solid tumors].
Topics: Antineoplastic Agents; Breast Neoplasms; Cobalt Isotopes; Cyclophosphamide; Drug Combinations; Femal | 1971 |
[Intra-arterial chemotherapy of head and neck tumors: statistical study of 129 cases treated at the Institut Gustave Roussy].
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Facial Neoplasms | 1973 |
[Intra-arterial chemotherapy of head and neck tumors: statistical study of 129 cases treated at the Institut Gustave Roussy].
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Facial Neoplasms | 1973 |
[Intra-arterial chemotherapy of head and neck tumors: statistical study of 129 cases treated at the Institut Gustave Roussy].
Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Facial Neoplasms | 1973 |
Some aspects of the use of cytostatic drugs in dermatology.
Topics: Colchicine; Dactinomycin; Fluorouracil; Humans; Melanoma; Methotrexate; Mycosis Fungoides; Nitrogen | 1966 |
Some aspects of the use of cytostatic drugs in dermatology.
Topics: Colchicine; Dactinomycin; Fluorouracil; Humans; Melanoma; Methotrexate; Mycosis Fungoides; Nitrogen | 1966 |
Some aspects of the use of cytostatic drugs in dermatology.
Topics: Colchicine; Dactinomycin; Fluorouracil; Humans; Melanoma; Methotrexate; Mycosis Fungoides; Nitrogen | 1966 |
[Clinical picture and radiotherapy of malignant vulvar neoplasms].
Topics: Adult; Age Factors; Aged; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Melanoma; Middle A | 1973 |
[Clinical picture and radiotherapy of malignant vulvar neoplasms].
Topics: Adult; Age Factors; Aged; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Melanoma; Middle A | 1973 |
[Clinical picture and radiotherapy of malignant vulvar neoplasms].
Topics: Adult; Age Factors; Aged; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Melanoma; Middle A | 1973 |
Combination chemotherapy using cyclophosphamide, vincristine, methotrexate and 5-fluorouracil in solid tumors.
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Cyclophosphamide; Female; Fibrosarcoma; Fluorouraci | 1969 |
Combination chemotherapy using cyclophosphamide, vincristine, methotrexate and 5-fluorouracil in solid tumors.
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Cyclophosphamide; Female; Fibrosarcoma; Fluorouraci | 1969 |
Combination chemotherapy using cyclophosphamide, vincristine, methotrexate and 5-fluorouracil in solid tumors.
Topics: Adenocarcinoma; Adult; Carcinoma, Squamous Cell; Cyclophosphamide; Female; Fibrosarcoma; Fluorouraci | 1969 |
Lactic dehydrogenase isoenzyme alterations in malignant disease of the liver.
Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Bronchial Neoplasms; Carcinoma, Hepatocellular; C | 1971 |
Lactic dehydrogenase isoenzyme alterations in malignant disease of the liver.
Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Bronchial Neoplasms; Carcinoma, Hepatocellular; C | 1971 |
Lactic dehydrogenase isoenzyme alterations in malignant disease of the liver.
Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Bronchial Neoplasms; Carcinoma, Hepatocellular; C | 1971 |
Axillary metastases from unknown primary sites.
Topics: Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Squamous Cel | 1973 |
Axillary metastases from unknown primary sites.
Topics: Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Squamous Cel | 1973 |
Axillary metastases from unknown primary sites.
Topics: Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Squamous Cel | 1973 |
Experience with infusion and resection in cancer of the liver.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Hepatocellular; Catheterization; Colonic Neoplasms; Female | 1974 |
Experience with infusion and resection in cancer of the liver.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Hepatocellular; Catheterization; Colonic Neoplasms; Female | 1974 |
Experience with infusion and resection in cancer of the liver.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Hepatocellular; Catheterization; Colonic Neoplasms; Female | 1974 |
Tumors of the skin. Premalignment and malignant.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorouracil; Humans; Kera | 1974 |
Tumors of the skin. Premalignment and malignant.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorouracil; Humans; Kera | 1974 |
Tumors of the skin. Premalignment and malignant.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diagnosis, Differential; Fluorouracil; Humans; Kera | 1974 |
[Clinical results after synchronised radiotherapy in 21 cases of human malignomas (author's transl)].
Topics: Adult; Aged; Facial Neoplasms; Female; Fluorouracil; Follow-Up Studies; Germany, West; Humans; Laryn | 1974 |
[Clinical results after synchronised radiotherapy in 21 cases of human malignomas (author's transl)].
Topics: Adult; Aged; Facial Neoplasms; Female; Fluorouracil; Follow-Up Studies; Germany, West; Humans; Laryn | 1974 |
[Clinical results after synchronised radiotherapy in 21 cases of human malignomas (author's transl)].
Topics: Adult; Aged; Facial Neoplasms; Female; Fluorouracil; Follow-Up Studies; Germany, West; Humans; Laryn | 1974 |
[Application of morphological and histochemical methods for evaluation of cytostatic effects on organ cultures of malignant tumors].
Topics: Animals; Antineoplastic Agents; Carcinoma; Culture Techniques; Female; Fluorouracil; Histocytochemis | 1974 |
[Application of morphological and histochemical methods for evaluation of cytostatic effects on organ cultures of malignant tumors].
Topics: Animals; Antineoplastic Agents; Carcinoma; Culture Techniques; Female; Fluorouracil; Histocytochemis | 1974 |
[Application of morphological and histochemical methods for evaluation of cytostatic effects on organ cultures of malignant tumors].
Topics: Animals; Antineoplastic Agents; Carcinoma; Culture Techniques; Female; Fluorouracil; Histocytochemis | 1974 |
Results in 169 patients with cancer of the head and neck treated by intra-arterial infusion therapy.
Topics: Antineoplastic Agents; Brachial Artery; Brachiocephalic Trunk; Carcinoma, Squamous Cell; Carotid Art | 1972 |
Results in 169 patients with cancer of the head and neck treated by intra-arterial infusion therapy.
Topics: Antineoplastic Agents; Brachial Artery; Brachiocephalic Trunk; Carcinoma, Squamous Cell; Carotid Art | 1972 |
Results in 169 patients with cancer of the head and neck treated by intra-arterial infusion therapy.
Topics: Antineoplastic Agents; Brachial Artery; Brachiocephalic Trunk; Carcinoma, Squamous Cell; Carotid Art | 1972 |
Cancer chemotherapy. I. Methods, agents and overall results in 400 patients.
Topics: Adenocarcinoma; Amides; Androgens; Breast Neoplasms; Colonic Neoplasms; Cyclophosphamide; Estrogens; | 1972 |
Cancer chemotherapy. I. Methods, agents and overall results in 400 patients.
Topics: Adenocarcinoma; Amides; Androgens; Breast Neoplasms; Colonic Neoplasms; Cyclophosphamide; Estrogens; | 1972 |
Cancer chemotherapy. I. Methods, agents and overall results in 400 patients.
Topics: Adenocarcinoma; Amides; Androgens; Breast Neoplasms; Colonic Neoplasms; Cyclophosphamide; Estrogens; | 1972 |
[Principles, technic and clinical performance of synchronized radiotherapy].
Topics: Adenocarcinoma; Adult; Aged; Androstanols; Bone Neoplasms; Breast Neoplasms; Carcinoma; Carcinoma, S | 1972 |
[Principles, technic and clinical performance of synchronized radiotherapy].
Topics: Adenocarcinoma; Adult; Aged; Androstanols; Bone Neoplasms; Breast Neoplasms; Carcinoma; Carcinoma, S | 1972 |
[Principles, technic and clinical performance of synchronized radiotherapy].
Topics: Adenocarcinoma; Adult; Aged; Androstanols; Bone Neoplasms; Breast Neoplasms; Carcinoma; Carcinoma, S | 1972 |
[Histological findings during the treatment of skin neoplasias with 5-fluorouracil ointment].
Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Melanoma; Middl | 1972 |
[Histological findings during the treatment of skin neoplasias with 5-fluorouracil ointment].
Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Melanoma; Middl | 1972 |
[Histological findings during the treatment of skin neoplasias with 5-fluorouracil ointment].
Topics: Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Melanoma; Middl | 1972 |
The effects of cytostatic drugs on transplanted tumours. An investigation of the correlation between in vivo and in vitro results.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cricetinae; Cytarabine; Dauno | 1974 |
The effects of cytostatic drugs on transplanted tumours. An investigation of the correlation between in vivo and in vitro results.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cricetinae; Cytarabine; Dauno | 1974 |
The effects of cytostatic drugs on transplanted tumours. An investigation of the correlation between in vivo and in vitro results.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cricetinae; Cytarabine; Dauno | 1974 |
Xeroderma pigmentosum--five-year arrest after total resurfacing of the face.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Child, Preschool; Dermabrasion; Electrosurgery; Fac | 1970 |
Xeroderma pigmentosum--five-year arrest after total resurfacing of the face.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Child, Preschool; Dermabrasion; Electrosurgery; Fac | 1970 |
Xeroderma pigmentosum--five-year arrest after total resurfacing of the face.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Child, Preschool; Dermabrasion; Electrosurgery; Fac | 1970 |
Regional chemotherapy of cancer of the head and neck.
Topics: Antineoplastic Agents; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; Fluorouracil; Head; Head | 1966 |
Regional chemotherapy of cancer of the head and neck.
Topics: Antineoplastic Agents; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; Fluorouracil; Head; Head | 1966 |
Regional chemotherapy of cancer of the head and neck.
Topics: Antineoplastic Agents; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; Fluorouracil; Head; Head | 1966 |
[Are combinations more effective than monotherapy in the matter of antiocancer chemotherapy?].
Topics: Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Drug Synergism; Female; Fluorouracil; Fl | 1968 |
[Are combinations more effective than monotherapy in the matter of antiocancer chemotherapy?].
Topics: Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Drug Synergism; Female; Fluorouracil; Fl | 1968 |
[Are combinations more effective than monotherapy in the matter of antiocancer chemotherapy?].
Topics: Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Drug Synergism; Female; Fluorouracil; Fl | 1968 |
[Antineoplastic polychemotherapy in thoracic pathology].
Topics: Adrenalectomy; Aged; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Cortisone; Cyclop | 1968 |
[Antineoplastic polychemotherapy in thoracic pathology].
Topics: Adrenalectomy; Aged; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Cortisone; Cyclop | 1968 |
[Antineoplastic polychemotherapy in thoracic pathology].
Topics: Adrenalectomy; Aged; Antineoplastic Agents; Breast Neoplasms; Bronchial Neoplasms; Cortisone; Cyclop | 1968 |
[Chemotherapy of solid tumors].
Topics: Antineoplastic Agents; Child; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Synergism; Fluorour | 1970 |
[Chemotherapy of solid tumors].
Topics: Antineoplastic Agents; Child; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Synergism; Fluorour | 1970 |
[Chemotherapy of solid tumors].
Topics: Antineoplastic Agents; Child; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Synergism; Fluorour | 1970 |
Evaluation of hepatic dearterialization in primary and secondary cancer of the liver.
Topics: Adult; Aged; Female; Fluorouracil; Hepatic Artery; Humans; Ligation; Liver; Liver Neoplasms; Lymphom | 1972 |
Evaluation of hepatic dearterialization in primary and secondary cancer of the liver.
Topics: Adult; Aged; Female; Fluorouracil; Hepatic Artery; Humans; Ligation; Liver; Liver Neoplasms; Lymphom | 1972 |
Evaluation of hepatic dearterialization in primary and secondary cancer of the liver.
Topics: Adult; Aged; Female; Fluorouracil; Hepatic Artery; Humans; Ligation; Liver; Liver Neoplasms; Lymphom | 1972 |
Expectations and pitfalls of chemotherapy in a university cancer clinic.
Topics: Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Gastrointestinal Neoplasms; Hospitals, Tea | 1972 |
Expectations and pitfalls of chemotherapy in a university cancer clinic.
Topics: Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Gastrointestinal Neoplasms; Hospitals, Tea | 1972 |
Expectations and pitfalls of chemotherapy in a university cancer clinic.
Topics: Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Gastrointestinal Neoplasms; Hospitals, Tea | 1972 |
International Cancer Conference and Eighth International Pigment Cell Conference.
Topics: Colchicine; Fluorouracil; Humans; Melanoma; Methylamines; Skin Neoplasms | 1972 |
International Cancer Conference and Eighth International Pigment Cell Conference.
Topics: Colchicine; Fluorouracil; Humans; Melanoma; Methylamines; Skin Neoplasms | 1972 |
International Cancer Conference and Eighth International Pigment Cell Conference.
Topics: Colchicine; Fluorouracil; Humans; Melanoma; Methylamines; Skin Neoplasms | 1972 |
Review of a 3-year experience with topical chemotherapy and immunotherapy of superficial cutaneous neoplasms.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chlorine; Facial Neoplasms; | 1971 |
Review of a 3-year experience with topical chemotherapy and immunotherapy of superficial cutaneous neoplasms.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chlorine; Facial Neoplasms; | 1971 |
Review of a 3-year experience with topical chemotherapy and immunotherapy of superficial cutaneous neoplasms.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chlorine; Facial Neoplasms; | 1971 |
A primary melanocarcinoma of the cervix.
Topics: Adult; Cervix Uteri; Female; Fluorouracil; Humans; Imidazoles; Melanoma; Melphalan; Neoplasm Metasta | 1971 |
A primary melanocarcinoma of the cervix.
Topics: Adult; Cervix Uteri; Female; Fluorouracil; Humans; Imidazoles; Melanoma; Melphalan; Neoplasm Metasta | 1971 |
A primary melanocarcinoma of the cervix.
Topics: Adult; Cervix Uteri; Female; Fluorouracil; Humans; Imidazoles; Melanoma; Melphalan; Neoplasm Metasta | 1971 |
[Gallbladder cancer].
Topics: Adenocarcinoma; Adenoma; Carcinoma; Cholelithiasis; Fluorouracil; Gallbladder Neoplasms; Humans; Mel | 1971 |
[Gallbladder cancer].
Topics: Adenocarcinoma; Adenoma; Carcinoma; Cholelithiasis; Fluorouracil; Gallbladder Neoplasms; Humans; Mel | 1971 |
[Gallbladder cancer].
Topics: Adenocarcinoma; Adenoma; Carcinoma; Cholelithiasis; Fluorouracil; Gallbladder Neoplasms; Humans; Mel | 1971 |
Seventy-five cases of solid tumours treated by a modified quadruple chemotherapy regime.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Bronchial Neoplasms; Child; Cyclophosphamide; Female; Flu | 1971 |
Seventy-five cases of solid tumours treated by a modified quadruple chemotherapy regime.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Bronchial Neoplasms; Child; Cyclophosphamide; Female; Flu | 1971 |
Seventy-five cases of solid tumours treated by a modified quadruple chemotherapy regime.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Bronchial Neoplasms; Child; Cyclophosphamide; Female; Flu | 1971 |
Xeroderma pigmentosum.
Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Child, Preschool; Eyelid Neoplasms; Female; | 1971 |
Xeroderma pigmentosum.
Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Child, Preschool; Eyelid Neoplasms; Female; | 1971 |
Xeroderma pigmentosum.
Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Child, Preschool; Eyelid Neoplasms; Female; | 1971 |
[Apropos of 40 cases of malignant tumors treated by local-regional and general chemotherapy in a surgical department].
Topics: Adolescent; Adult; Aminopterin; Back; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemotherapy, | 1969 |
[Apropos of 40 cases of malignant tumors treated by local-regional and general chemotherapy in a surgical department].
Topics: Adolescent; Adult; Aminopterin; Back; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemotherapy, | 1969 |
[Apropos of 40 cases of malignant tumors treated by local-regional and general chemotherapy in a surgical department].
Topics: Adolescent; Adult; Aminopterin; Back; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemotherapy, | 1969 |
[Treatment of skin cancer].
Topics: Age Factors; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Lip Neoplasms; Male; Melanoma; Pro | 1971 |
[Treatment of skin cancer].
Topics: Age Factors; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Lip Neoplasms; Male; Melanoma; Pro | 1971 |
[Treatment of skin cancer].
Topics: Age Factors; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Lip Neoplasms; Male; Melanoma; Pro | 1971 |
Effects of endoxan & 5-fluorouracil on the primary culture of melanoma cells.
Topics: Animals; Cell Line; Culture Techniques; Cyclophosphamide; Fluorouracil; Melanoma; Mice | 1969 |
Effects of endoxan & 5-fluorouracil on the primary culture of melanoma cells.
Topics: Animals; Cell Line; Culture Techniques; Cyclophosphamide; Fluorouracil; Melanoma; Mice | 1969 |
Effects of endoxan & 5-fluorouracil on the primary culture of melanoma cells.
Topics: Animals; Cell Line; Culture Techniques; Cyclophosphamide; Fluorouracil; Melanoma; Mice | 1969 |
The aging skin: problems and their causes.
Topics: Aged; Aging; Arsenicals; Balanitis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorou | 1970 |
The aging skin: problems and their causes.
Topics: Aged; Aging; Arsenicals; Balanitis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorou | 1970 |
The aging skin: problems and their causes.
Topics: Aged; Aging; Arsenicals; Balanitis; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Fluorou | 1970 |
[Distribution of 5-fluorouracil in the bodies of mice with tumors of different sensitivities to the drug].
Topics: Adenocarcinoma; Animals; Fluorouracil; Kidney; Liver; Mammary Neoplasms, Experimental; Melanoma; Mic | 1970 |
[Distribution of 5-fluorouracil in the bodies of mice with tumors of different sensitivities to the drug].
Topics: Adenocarcinoma; Animals; Fluorouracil; Kidney; Liver; Mammary Neoplasms, Experimental; Melanoma; Mic | 1970 |
[Distribution of 5-fluorouracil in the bodies of mice with tumors of different sensitivities to the drug].
Topics: Adenocarcinoma; Animals; Fluorouracil; Kidney; Liver; Mammary Neoplasms, Experimental; Melanoma; Mic | 1970 |
Local chemotherapy of cutaneous neoplasms.
Topics: Adenocarcinoma; Allergy and Immunology; Antineoplastic Agents; Carcinoma, Squamous Cell; Dactinomyci | 1970 |
Local chemotherapy of cutaneous neoplasms.
Topics: Adenocarcinoma; Allergy and Immunology; Antineoplastic Agents; Carcinoma, Squamous Cell; Dactinomyci | 1970 |
Local chemotherapy of cutaneous neoplasms.
Topics: Adenocarcinoma; Allergy and Immunology; Antineoplastic Agents; Carcinoma, Squamous Cell; Dactinomyci | 1970 |